Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CR2,Complement receptor type 2,Lifestyle factors,X1050.Time spend outdoors in summer,50391,-0.0142383688839866,0.0257287306841354,-0.0646666810248921,0.0361899432569188,0.579992840061927
CR2,Complement receptor type 2,Lifestyle factors,X1060.Time spent outdoors in winter,48192,-0.0357300075504254,0.0286835990060433,-0.0919498616022703,0.0204898465014195,0.212904197810562
CR2,Complement receptor type 2,Physical activities,X1070.Time spent watching television (TV),51200,0.054690082446905,0.0253640529601371,0.00497653864503637,0.104403626248774,0.0310782263121048
CR2,Complement receptor type 2,Physical activities,X1080.Time spent using computer,48209,-0.00606495649637252,0.0253760697051007,-0.05580205311837,0.0436721401256249,0.811105763250388
CR2,Complement receptor type 2,Physical activities,X1090.Time spent driving,45456,-0.0590102680034172,0.0280061266651319,-0.113902276267076,-0.00411825973975874,0.0351281084647535
CR2,Complement receptor type 2,Lifestyle factors,X1160.Sleep duration,52271,0.0474284811010489,0.0232289676589072,0.0018997044895909,0.0929572577125069,0.041184252315835
CR2,Complement receptor type 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36058,-0.0177644040859545,0.019054805377132,-0.0551118226251332,0.0195830144532242,0.351222287244748
CR2,Complement receptor type 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36058,0.0177919964373821,0.0209959199490556,-0.023360006662767,0.0589439995375311,0.396797967322326
CR2,Complement receptor type 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36058,-0.03123499779642,0.0222248554582214,-0.0747957144945339,0.012325718901694,0.159941534254733
CR2,Complement receptor type 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36058,-0.0101889206669786,0.0227494774027764,-0.0547778963764203,0.0344000550424631,0.654256469203779
CR2,Complement receptor type 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36058,-0.0198866149531847,0.0233291397620143,-0.0656117288867326,0.0258384989803632,0.393999129983564
CR2,Complement receptor type 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36058,-0.0229276570183955,0.0624031742683275,-0.145237878584317,0.0993825645475265,0.713322362696662
CR2,Complement receptor type 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36058,0.0800722565821225,0.0725665014818126,-0.0621580863222302,0.222302599486475,0.2698748692025
CR2,Complement receptor type 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36058,0.0160847722183527,0.0373461665487017,-0.0571137142171026,0.089283258653808,0.666703282311296
CR2,Complement receptor type 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36058,2.42091273968478e-05,0.0282083352997055,-0.055264128060026,0.0553125463148197,0.999315257744953
CR2,Complement receptor type 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36058,-0.0130951488486124,0.0191257938394279,-0.0505817047738912,0.0243914070766664,0.493563838135947
CR2,Complement receptor type 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36058,0.0150557596191012,0.0301985517470949,-0.0441334018052048,0.0742449210434072,0.618104801109182
CR2,Complement receptor type 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36058,-0.0105624063416955,0.0142609686972082,-0.0385139049882236,0.0173890923048326,0.458928154701354
CR2,Complement receptor type 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36058,0.0378352312804743,0.0195322344192112,-0.000447948181179748,0.0761184107421283,0.0527749672111689
CR2,Complement receptor type 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36058,-0.00815643315986768,0.0309922636492595,-0.0689012699124164,0.052588403592681,0.792421870475573
CR2,Complement receptor type 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36058,0.0409160729085169,0.0287523090416165,-0.0154384528130515,0.0972705986300853,0.15476248537879
CR2,Complement receptor type 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36058,0.0378660529004354,0.0350623452857955,-0.0308561438597238,0.106588249660595,0.280193360110852
CR2,Complement receptor type 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36058,0.0328451878128805,0.0341606719123433,-0.0341097291353123,0.0998001047610733,0.336336384230529
CR2,Complement receptor type 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36058,0.0151463212228283,0.0218497672537967,-0.0276792225946133,0.0579718650402699,0.488203837859582
CR2,Complement receptor type 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36058,-0.0289098354639778,0.0213616639337911,-0.0707786967742084,0.0129590258462528,0.175984447269525
CR2,Complement receptor type 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36058,-0.0327350291424287,0.0237012516571738,-0.0791894823904894,0.0137194241056319,0.167273635631334
CR2,Complement receptor type 2,Health and medical history,X120040.Fatigue severity over the past week,36064,0.0857053699645072,0.0448167115371676,-0.0021353846483413,0.173546124577356,0.0558691870016041
CR2,Complement receptor type 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,36067,0.0745353732605631,0.0439402461090506,-0.0115875091131761,0.160658255634302,0.0898727824255041
CR2,Complement receptor type 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,36067,0.0371918821992704,0.0484399999538296,-0.0577505177102356,0.132134282108776,0.442634589793261
CR2,Complement receptor type 2,Health and medical history,X120098.Mobility problems today,36069,-0.0139112741937977,0.0517389976098847,-0.115319709509172,0.0874971611215764,0.788034030855282
CR2,Complement receptor type 2,Health and medical history,X120099.Self-care problems today,36069,0.0789147293307429,0.0778073752254428,-0.073587726111125,0.231417184772611,0.310504931938142
CR2,Complement receptor type 2,Health and medical history,X120100.Problems doing usual activities,36069,-0.010697650100867,0.049697036095326,-0.108103840847706,0.086708540645972,0.829572593955329
CR2,Complement receptor type 2,Health and medical history,X120101.Pain or discomfort today,36069,-0.0432221011516501,0.044267418015004,-0.129986240461058,0.0435420381577578,0.328904695124442
CR2,Complement receptor type 2,Health and medical history,X120102.Anxiety or depression today,36069,0.0430423064902305,0.0571203434248044,-0.068913566622386,0.154998179602847,0.451150897844089
CR2,Complement receptor type 2,Health and medical history,X120103.Scale to indicate how health is today,36052,-0.0078128282006895,0.00622555887621525,-0.0200149235980714,0.00438926719669239,0.209532587041295
CR2,Complement receptor type 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36053,-0.0282290360205296,0.0560276711229283,-0.138043271421469,0.0815851993804099,0.614388032679821
CR2,Complement receptor type 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36051,-0.0263137455146546,0.0597731475319919,-0.143469114677359,0.0908416236480495,0.659785575221618
CR2,Complement receptor type 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36057,-0.0138923832669467,0.0449470835020426,-0.10198866693095,0.0742039003970568,0.757266962593841
CR2,Complement receptor type 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36062,0.0889282470840198,0.045481215434568,-0.00021493516773341,0.178071429335773,0.0505879987395205
CR2,Complement receptor type 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36061,0.0330874751531514,0.0662112282952575,-0.0966865323055534,0.162861482611856,0.617282732234227
CR2,Complement receptor type 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,36044,0.0269165407481492,0.0630937510185282,-0.0967472112481661,0.150580292744465,0.669674417735193
CR2,Complement receptor type 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,36064,0.100606446901567,0.0597143882814024,-0.0164337541299818,0.217646647933116,0.0920701277587418
CR2,Complement receptor type 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36056,0.0380567453848926,0.0874705668508899,-0.133385565642852,0.209499056412637,0.663516531574718
CR2,Complement receptor type 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36023,-0.031815221597022,0.124127249233096,-0.27510463009389,0.211474186899846,0.797717546204451
CR2,Complement receptor type 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33238,0.0301395684017505,0.0632926075945292,-0.0939139424835268,0.154193079287028,0.633958519038536
CR2,Complement receptor type 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49751,0.0548076417819767,0.0564110024399857,-0.0557579230003952,0.165373206564349,0.331272058556382
CR2,Complement receptor type 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48525,-0.100055477822787,0.0323849092802433,-0.163529900012064,-0.0365810556335101,0.00200721735784393
CR2,Complement receptor type 2,Diet and food preferences,X1289.Cooked vegetable intake,51333,-0.0126090317305916,0.0243325805188067,-0.0603008895474528,0.0350828260862696,0.604326974820062
CR2,Complement receptor type 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50484,-0.0242466561150054,0.0251907598960505,-0.0736205455112644,0.0251272332812536,0.335798182426872
CR2,Complement receptor type 2,Diet and food preferences,X1309.Fresh fruit intake,51193,0.0921058840241551,0.0256357141357584,0.0418598843180687,0.142351883730242,0.000327745882943006
CR2,Complement receptor type 2,Diet and food preferences,X1319.Dried fruit intake,50191,0.027017753005112,0.0271325298597663,-0.0261620055200301,0.080197511530254,0.31937318164321
CR2,Complement receptor type 2,Health and medical history,X134.Number of self-reported cancers,52421,0.0356721630020318,0.0497659901883252,-0.0618691777670857,0.133213503771149,0.473505765014168
CR2,Complement receptor type 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52422,0.146082149093487,0.0243699455431164,0.0983170558289792,0.193847242357995,2.07230975482032e-09
CR2,Complement receptor type 2,Health and medical history,"X136.Number of operations, self-reported",52422,0.0700173552367862,0.0232590427506783,0.0244296314454568,0.115605079028116,0.00261238661852015
CR2,Complement receptor type 2,Health and medical history,X137.Number of treatments or medications taken,52422,0.151199859075608,0.0239511721350022,0.104255561691004,0.198144156460212,2.78794999083654e-10
CR2,Complement receptor type 2,Diet and food preferences,X1438.Bread intake,51872,0.0128142008288835,0.00349111820622142,0.00597160914468948,0.0196567925130774,0.000242603376824849
CR2,Complement receptor type 2,Diet and food preferences,X1458.Cereal intake,51201,0.12272104188649,0.0242882651578366,0.0751160421771302,0.17032604159585,4.39027573509644e-07
CR2,Complement receptor type 2,Diet and food preferences,X1488.Tea intake,51545,0.00480449390321504,0.00343682021621491,-0.00193167372056619,0.0115406615269963,0.16214237509767
CR2,Complement receptor type 2,Diet and food preferences,X1498.Coffee intake,50565,-0.0463640654851902,0.0242013280342785,-0.0937986684323761,0.00107053746199575,0.0554079393508665
CR2,Complement receptor type 2,Diet and food preferences,X1528.Water intake,50245,-0.0217857742838238,0.0244535728242175,-0.0697147770192902,0.0261432284516426,0.372990830885543
CR2,Complement receptor type 2,Lifestyle factors,X1568.Average weekly red wine intake,46735,-0.114988218164022,0.0268327265859987,-0.16758036227258,-0.0623960740554648,1.83374222344562e-05
CR2,Complement receptor type 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46725,-0.041554794319043,0.0281164907029255,-0.0966631160967771,0.0135535274586911,0.139438282935619
CR2,Complement receptor type 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46799,-0.168338255703776,0.02813003474378,-0.223473123801584,-0.113203387605967,2.21410225040916e-09
CR2,Complement receptor type 2,Lifestyle factors,X1598.Average weekly spirits intake,46728,-0.017162912953237,0.0290073525188719,-0.0740173238902259,0.0396914979837519,0.554075904223521
CR2,Complement receptor type 2,Lifestyle factors,X1608.Average weekly fortified wine intake,46767,0.0533274830518288,0.0515448453225805,-0.0477004137804289,0.154355379884086,0.300876903561818
CR2,Complement receptor type 2,Lifestyle factors,X1737.Childhood sunburn occasions,46153,-0.0322203949876462,0.0284396432189893,-0.0879620956968652,0.0235213057215728,0.25725513892182
CR2,Complement receptor type 2,Health and medical history,X1807.Father's age at death,46325,0.00599831795851456,0.00401980996051372,-0.00188050956409233,0.0138771454811215,0.135667288269286
CR2,Complement receptor type 2,Health and medical history,X1845.Mother's age,37382,0.00185915339234991,0.00872282001167385,-0.0152375738305308,0.0189558806152306,0.831225258431169
CR2,Complement receptor type 2,Health and medical history,X1873.Number of full brothers,52007,-0.0185961138066922,0.0233488551177761,-0.0643598698375334,0.027167642224149,0.425780641122901
CR2,Complement receptor type 2,Health and medical history,X1883.Number of full sisters,52009,0.00570542837785626,0.0234574596742804,-0.0402711925837332,0.0516820493394458,0.80783363689811
CR2,Complement receptor type 2,Physical measures,X20015.Sitting height,52211,0.0172895589268665,0.00449607614946086,0.00847724967392321,0.0261018681798098,0.000120633719549226
CR2,Complement receptor type 2,Cognitive function,X20016.Fluid intelligence score,36216,-0.0718578861027554,0.0383813647985705,-0.147085361107954,0.00336958890244284,0.0612162275525814
CR2,Complement receptor type 2,Cognitive function,X20018.Prospective memory result,36565,0.0948541723946211,0.0506624704795027,-0.00444426974520419,0.194152614534446,0.061204923219417
CR2,Complement receptor type 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36128,0.0254158576925936,0.00617274250561466,0.0133172823815889,0.0375144330035983,3.87210140446974e-05
CR2,Complement receptor type 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36131,0.0169531674367947,0.0062123029968092,0.00477705356304868,0.0291292813105407,0.00636806464802106
CR2,Complement receptor type 2,Cognitive function,X20023.Mean time to correctly identify matches,52109,0.0100998279226981,0.00354001810502802,0.00316139243684315,0.017038263408553,0.00433404012760691
CR2,Complement receptor type 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48935,-0.00257067442342899,0.00789397164748679,-0.0180428588525031,0.0129015100056451,0.744692283518478
CR2,Complement receptor type 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48486,0.00202333974250985,0.017729738283526,-0.0327269472932012,0.0367736267782209,0.909142836123207
CR2,Complement receptor type 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48445,-0.00333649585017893,0.0232536433624803,-0.0489136368406403,0.0422406451402824,0.885910419374056
CR2,Complement receptor type 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48470,0.00641457239877374,0.0210515325691988,-0.034846431436856,0.0476755762344035,0.760591674508334
CR2,Complement receptor type 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48491,0.0113242575504702,0.0140376520070554,-0.0161895403833584,0.0388380554842988,0.419845554183387
CR2,Complement receptor type 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48664,0.0158541465331401,0.0100802288272826,-0.00390310196833386,0.0356113950346141,0.115781761959232
CR2,Complement receptor type 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48611,-0.00951836410429807,0.0127783070055915,-0.0345638458352574,0.0155271176266612,0.456350233403882
CR2,Complement receptor type 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48505,-0.00282516102475641,0.0155185624725569,-0.033241543470968,0.0275912214214552,0.855545000804887
CR2,Complement receptor type 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48635,0.00804930394478381,0.0119665821815162,-0.0154051971309879,0.0315038050205556,0.501178675503087
CR2,Complement receptor type 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48722,0.0190813772034767,0.0089206208915721,0.00159696025599536,0.036565794150958,0.0324461330664509
CR2,Complement receptor type 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48576,0.0276877562253614,0.0122679925698116,0.00364249078853071,0.0517330216621921,0.024024451096628
CR2,Complement receptor type 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49735,0.0213664015909761,0.00940216852781104,0.00293815127646643,0.0397946519054857,0.0230664947262578
CR2,Complement receptor type 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49576,-0.0256809873980998,0.0131840517647077,-0.0515217288569269,0.000159754060727262,0.0514423117752757
CR2,Complement receptor type 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49495,-0.0196434359313771,0.0293938210401092,-0.0772553251699912,0.0379684533072369,0.503959367068814
CR2,Complement receptor type 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49530,0.0112254739253177,0.0156298053339911,-0.019408944529305,0.0418598923799403,0.472636167490357
CR2,Complement receptor type 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49681,-0.0169446381121746,0.0105497239722697,-0.0376220970978232,0.00373282087347398,0.108251791237709
CR2,Complement receptor type 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49572,-0.0291523434555093,0.0177234394642474,-0.0638902848054343,0.00558559789441566,0.100016386341339
CR2,Complement receptor type 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49540,-0.0202407501692554,0.0160436951353331,-0.0516863926345082,0.0112048922959974,0.207106262134651
CR2,Complement receptor type 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49549,-0.0221419616736304,0.0133882525808575,-0.0483829367321111,0.0040990133848502,0.0981760102177869
CR2,Complement receptor type 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49582,0.00269172874672672,0.0160580645548326,-0.0287820777807452,0.0341655352741987,0.866880129669423
CR2,Complement receptor type 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49789,0.0204052471475949,0.00807647804453214,0.00457535018031191,0.0362351441148779,0.0115276550425741
CR2,Complement receptor type 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49632,0.0270400792427894,0.0121551385053834,0.00321600777223797,0.0508641507133409,0.0261200100524859
CR2,Complement receptor type 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46658,0.00767542374649421,0.0129644929203818,-0.0177349823774542,0.0330858298704426,0.553835070665751
CR2,Complement receptor type 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46511,-0.0414513887761381,0.0525395048448711,-0.144428818272085,0.0615260407198092,0.430147819394197
CR2,Complement receptor type 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46504,-0.0198896277896688,0.0514878126297173,-0.120805740543915,0.0810264849645771,0.699280733790855
CR2,Complement receptor type 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46558,0.00131271418894871,0.0169726111703723,-0.031953603704981,0.0345790320828784,0.938351474539688
CR2,Complement receptor type 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46520,0.0221876039331123,0.0300528256951171,-0.0367159344293173,0.0810911422955418,0.460349866111133
CR2,Complement receptor type 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46555,-0.041118714131906,0.0216103385273553,-0.0834749776455224,0.00123754938171048,0.0570913147984696
CR2,Complement receptor type 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46526,-0.0256974134419035,0.0248636162476844,-0.074430101287365,0.023035274403558,0.301367621493203
CR2,Complement receptor type 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46530,-0.00185287173752934,0.0239852869760706,-0.0488640342106276,0.045158290735569,0.93842525225865
CR2,Complement receptor type 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46537,-0.0291455930083343,0.0191814449353105,-0.0667412250815429,0.00845003906487431,0.128662346109304
CR2,Complement receptor type 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46553,0.0199339357478253,0.0242043205946573,-0.0275065326177029,0.0673744041133536,0.410195256779357
CR2,Complement receptor type 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46724,0.0150188674099508,0.00984304727681639,-0.00427350525260937,0.0343112400725109,0.127068376479211
CR2,Complement receptor type 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46624,0.0483319867240771,0.0137274929932865,0.0214261004572355,0.0752378729909187,0.00043128208162285
CR2,Complement receptor type 2,Mental health,X20127.Neuroticism score,47803,0.0583767112136597,0.0243594521260544,0.0106321850465932,0.106121237380726,0.0165633298801758
CR2,Complement receptor type 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36216,-0.0191801413040615,0.0388220027335089,-0.0952712666617389,0.056910984053616,0.621282756892175
CR2,Complement receptor type 2,Lifestyle factors,X20161.Pack years of smoking,36878,0.0109111487050954,0.00603626443960014,-0.000919929596520831,0.0227422270067117,0.0707051371085888
CR2,Complement receptor type 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36878,0.00989313788730763,0.00595256936992371,-0.00177389807774284,0.0215601738523581,0.0965517290553974
CR2,Complement receptor type 2,Cognitive function,X20191.Fluid intelligence score,34264,-0.0910007978751568,0.0458830664536112,-0.180931608124235,-0.00106998762607886,0.0473800274776999
CR2,Complement receptor type 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34265,-0.0641142793896287,0.0466830648510628,-0.155613086497712,0.0273845277184545,0.169684104930416
CR2,Complement receptor type 2,Cognitive function,X20240.Maximum digits remembered correctly,33719,-0.0767346237269603,0.0495699690981249,-0.173891763159285,0.0204225157053646,0.12168269690217
CR2,Complement receptor type 2,Physical measures,X20255.Spirometry QC measure,45613,0.00317315494161878,0.0302962585539054,-0.0562075118240358,0.0625538217072733,0.916585324730962
CR2,Complement receptor type 2,Eye measures,X20261.avMSE,33828,-0.00712630345319862,0.00756621848184706,-0.0219560916776189,0.00770348477122162,0.346308860999326
CR2,Complement receptor type 2,Eye measures,X20262.Myopia diagnosis,33828,0.0864246943570829,0.0588181535579654,-0.0288588866165293,0.201708275330695,0.141796955207554
CR2,Complement receptor type 2,NMR metabolomics,X20280.Glucose-lactate,42189,0.0190329917459468,0.00443151135281102,0.0103472294944372,0.0277187539974564,1.75968930983226e-05
CR2,Complement receptor type 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,42214,0.0208384516449046,0.00467231532074681,0.0116807136162408,0.0299961896735683,8.2622123542133e-06
CR2,Complement receptor type 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35977,-0.0122621132847847,0.0289181258797369,-0.0689416400090691,0.0444174134394997,0.671557297916106
CR2,Complement receptor type 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35977,0.0282316243943241,0.0647048844126665,-0.0985899490545023,0.15505319784315,0.662621946745558
CR2,Complement receptor type 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35977,0.0829504157766796,0.0773828503183532,-0.0687199708472928,0.234620802400652,0.283778315255971
CR2,Complement receptor type 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35977,0.0380499623501404,0.0281345242685789,-0.0170937052162743,0.093193629916555,0.176279391637965
CR2,Complement receptor type 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35977,-0.035525707552564,0.04024063765931,-0.114397357364812,0.0433459422596835,0.377356017529257
CR2,Complement receptor type 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35980,0.0995450360913824,0.0539903508584468,-0.00627605159117334,0.205366123773938,0.0652587644000782
CR2,Complement receptor type 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35980,0.0381616507663927,0.0339382394116984,-0.0283572984805362,0.104680600013322,0.260861272342424
CR2,Complement receptor type 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35980,0.0410730499058285,0.038913875778896,-0.0351981466208077,0.117344246432465,0.29123767420983
CR2,Complement receptor type 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35980,0.07294468265259,0.0567709813554645,-0.0383264408041204,0.1842158061093,0.198869718869985
CR2,Complement receptor type 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35980,0.0384735477530294,0.0637451006081779,-0.0864668494389992,0.163413944945058,0.546159407079624
CR2,Complement receptor type 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35980,0.0850120878303986,0.0410160981689398,0.00462053541927658,0.165403640241521,0.0382393336053002
CR2,Complement receptor type 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35980,0.078692037401303,0.0619756810324271,-0.0427802974222541,0.20016437222486,0.204222835926675
CR2,Complement receptor type 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35980,0.0334999287169747,0.0500726217764091,-0.0646424099647872,0.131642267398737,0.503499273794966
CR2,Complement receptor type 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35983,0.116956817090185,0.0838954151220002,-0.0474781965489357,0.281391830729305,0.163335772327567
CR2,Complement receptor type 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35983,0.0254186747938558,0.0371595513048192,-0.0474140457635899,0.0982513953513015,0.49397043673674
CR2,Complement receptor type 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35983,-0.0341153755520097,0.0488976407348816,-0.129954751392378,0.0617240002883583,0.485393302219586
CR2,Complement receptor type 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35983,-0.0846175123557328,0.102813489435873,-0.286131951650043,0.116896926938577,0.410523454791586
CR2,Complement receptor type 2,Diet and food preferences,X20600.Liking for adding salt to foods,36653,-0.0361285134641693,0.038607451116594,-0.111799117652693,0.0395420907243549,0.349408789105845
CR2,Complement receptor type 2,Diet and food preferences,X20601.Liking for aniseed,36653,-0.021935828713583,0.0383099777873822,-0.0970233851768521,0.0531517277496861,0.566939775267261
CR2,Complement receptor type 2,Diet and food preferences,X20602.Liking for apple juice,36653,-0.00608776160266675,0.0387583500055766,-0.082054127613597,0.0698786044082635,0.875193875448667
CR2,Complement receptor type 2,Diet and food preferences,X20603.Liking for apples,36653,0.0703951861333915,0.0397550479728377,-0.00752470789337029,0.148315080160153,0.0766446051837214
CR2,Complement receptor type 2,Diet and food preferences,X20604.Liking for asparagus,36653,-0.0671008145414771,0.0388175627362726,-0.143183237504572,0.00898160842161723,0.0839155030777957
CR2,Complement receptor type 2,Diet and food preferences,X20605.Liking for aubergine,36653,-0.0857166201879992,0.038613258086918,-0.161398606038359,-0.0100346343376398,0.0264550027888976
CR2,Complement receptor type 2,Diet and food preferences,X20606.Liking for avocados,36653,-0.0680224550043208,0.038385343535548,-0.143257728333995,0.00721281832535323,0.0764167227752412
CR2,Complement receptor type 2,Diet and food preferences,X20607.Liking for bacon,36653,-0.0619212897371118,0.0396124063099784,-0.139561606104669,0.0157190266304458,0.118049787739381
CR2,Complement receptor type 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36653,-0.0164398023998828,0.0390353656674943,-0.0929491191081716,0.0600695143084059,0.673655717046232
CR2,Complement receptor type 2,Diet and food preferences,X20609.Liking for bananas,36653,0.0465370101460868,0.0397505534681773,-0.0313740746515406,0.124448094943714,0.241743574042359
CR2,Complement receptor type 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36653,-0.00906695951360113,0.0393582595412183,-0.086209148214389,0.0680752291871868,0.817810182977828
CR2,Complement receptor type 2,Diet and food preferences,X20611.Liking for beef steak,36653,-0.0141782825270638,0.0397740685599638,-0.0921354569045928,0.0637788918504652,0.721497582066461
CR2,Complement receptor type 2,Diet and food preferences,X20612.Liking for beetroot,36653,-0.0600985519909789,0.0390237237828237,-0.136585050605313,0.0163879466233555,0.123587086911296
CR2,Complement receptor type 2,Diet and food preferences,X20613.Liking for bell pepper,36653,-0.0751524492614825,0.0387103764610492,-0.151024787125139,0.000719888602173979,0.0522442655522428
CR2,Complement receptor type 2,Diet and food preferences,X20614.Liking for bicycling,36653,-0.0667426794271941,0.0386008279812252,-0.142400302270396,0.00891494341600733,0.0838388950004008
CR2,Complement receptor type 2,Diet and food preferences,X20615.Liking for biscuits,36653,0.0213199215957674,0.0388083838952549,-0.0547445108389322,0.097384354030467,0.582771055478659
CR2,Complement receptor type 2,Diet and food preferences,X20616.Liking for bitter foods,36653,-0.0744972911826248,0.0389780146470535,-0.15089419989085,0.00189961752560011,0.0560061150051912
CR2,Complement receptor type 2,Diet and food preferences,X20617.Liking for bitter or ale,36653,-0.165874264119499,0.0390472464411411,-0.242406867144136,-0.0893416610948627,2.18078839542986e-05
CR2,Complement receptor type 2,Diet and food preferences,X20618.Liking for black olives,36653,-0.104207979991684,0.0384738282811944,-0.179616683422825,-0.0287992765605432,0.00677225395763031
CR2,Complement receptor type 2,Diet and food preferences,X20619.Liking for black pepper,36653,-0.112693496552211,0.0390589150948452,-0.189248970138107,-0.0361380229663143,0.00392181927843399
CR2,Complement receptor type 2,Diet and food preferences,X20620.Liking for blue cheese,36653,-0.0825708771859029,0.0389767310100659,-0.158965269965632,-0.00617648440617367,0.034166199729834
CR2,Complement receptor type 2,Diet and food preferences,X20621.Liking for bolognese sauce,36653,-0.0196487372324483,0.0393999427810588,-0.0968726250833236,0.057575150618427,0.618004635294499
CR2,Complement receptor type 2,Diet and food preferences,X20622.Liking for broad beans,36653,-0.0250734429714752,0.0389449840414386,-0.101405611692695,0.0512587257497445,0.51971246071128
CR2,Complement receptor type 2,Diet and food preferences,X20623.Liking for broccoli,36653,0.00576217505908473,0.0390696182940378,-0.0708142767972293,0.0823386269153988,0.882753068280692
CR2,Complement receptor type 2,Diet and food preferences,X20624.Liking for brown rice,36653,0.0139759818965727,0.0390928383660247,-0.0626459813008358,0.0905979450939811,0.720721311207515
CR2,Complement receptor type 2,Diet and food preferences,X20625.Liking for brussel sprouts,36653,-0.0221965592304367,0.0388836925957443,-0.0984085967180955,0.054015478257222,0.568120701782509
CR2,Complement receptor type 2,Diet and food preferences,X20626.Liking for burgers (meat),36653,0.00894709982585102,0.0389866433640867,-0.0674667211677588,0.0853609208194609,0.818492829688304
CR2,Complement receptor type 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36653,-0.135958481962616,0.0381909012485996,-0.210812648409871,-0.0611043155153602,0.000373037109311757
CR2,Complement receptor type 2,Diet and food preferences,X20628.Liking for butter on bread,36653,0.0161339975900504,0.0389063163477435,-0.0601223824515268,0.0923903776316276,0.678381092866836
CR2,Complement receptor type 2,Diet and food preferences,X20629.Liking for butternut squash,36653,-0.0390278661370256,0.0392188511125131,-0.115896814317551,0.0378410820435,0.319702840340197
CR2,Complement receptor type 2,Diet and food preferences,X20630.Liking for cabbage,36653,-0.013173583796982,0.0393850939391652,-0.0903683679177457,0.0640212003237818,0.738024997830517
CR2,Complement receptor type 2,Diet and food preferences,X20631.Liking for cake,36653,0.0762997704582812,0.0391782621586201,-0.000489623372614184,0.153089164289177,0.0515092448902137
CR2,Complement receptor type 2,Diet and food preferences,X20632.Liking for cake icing,36653,-0.0291607514173873,0.0383995512488005,-0.104423871865036,0.0461023690302617,0.447633507769244
CR2,Complement receptor type 2,Diet and food preferences,X20633.Liking for capers,36653,-0.0627209268964139,0.0387349632962984,-0.138641454957159,0.013199601164331,0.105436363966144
CR2,Complement receptor type 2,Diet and food preferences,X20634.Liking for cauliflower,36653,-0.0300336014605964,0.0392428418598494,-0.106949571505901,0.0468823685847084,0.444099379090862
CR2,Complement receptor type 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36653,-0.00404772774339388,0.0385868534976177,-0.0796779605987247,0.0715825051119369,0.916458456853629
CR2,Complement receptor type 2,Diet and food preferences,X20636.Liking for cheesecake,36653,0.0324596149153709,0.0389360441598649,-0.0438550316379642,0.108774261468706,0.40449457378694
CR2,Complement receptor type 2,Diet and food preferences,X20637.Liking for cherries,36653,0.0296821617374755,0.0395843770315358,-0.0479032172443348,0.107267540719286,0.453369771038385
CR2,Complement receptor type 2,Diet and food preferences,X20638.Liking for chicken,36653,0.0685234231413351,0.0405075495580428,-0.0108713739924289,0.147918220275099,0.0907569857891398
CR2,Complement receptor type 2,Diet and food preferences,X20639.Liking for chilli pepper,36653,-0.121022197420974,0.0384260755603931,-0.196337305519344,-0.0457070893226031,0.00164159608703855
CR2,Complement receptor type 2,Diet and food preferences,X20640.Liking for chips or french fries,36653,-0.0175426856997942,0.0389689917306607,-0.0939219094918891,0.0588365380923007,0.652599725684806
CR2,Complement receptor type 2,Diet and food preferences,X20641.Liking for cigarette smoking,36653,0.0327263679753604,0.0610277009240134,-0.0868879258357059,0.152340661786427,0.591797628036992
CR2,Complement receptor type 2,Diet and food preferences,X20642.Liking for cod,36653,0.0278455129968066,0.0397570873749337,-0.0500783782580635,0.105769404251677,0.483703304742402
CR2,Complement receptor type 2,Diet and food preferences,X20643.Liking for coffee with sugar,36653,0.0343371241564591,0.0402249783766941,-0.0445038334618613,0.11317808177478,0.393337159546766
CR2,Complement receptor type 2,Diet and food preferences,X20644.Liking for coffee without sugar,36653,-0.0839903490752123,0.0389532534964944,-0.160338725928341,-0.00764197222208322,0.0310989177332588
CR2,Complement receptor type 2,Diet and food preferences,X20645.Liking for coriander,36653,-0.165667513167909,0.0386757090064313,-0.241471902820514,-0.0898631235153032,1.86113684447636e-05
CR2,Complement receptor type 2,Diet and food preferences,X20646.Liking for corn flakes,36653,0.0946224104062609,0.0385253964524483,0.0191126333594623,0.17013218745306,0.0140662068493107
CR2,Complement receptor type 2,Diet and food preferences,X20647.Liking for cream,36653,0.125109606154977,0.0387905677260882,0.049080093411844,0.20113911889811,0.00126362079927893
CR2,Complement receptor type 2,Diet and food preferences,X20648.Liking for croissant,36653,-0.00499407241037559,0.0387500514639494,-0.0809441732797163,0.0709560284589651,0.897456523230517
CR2,Complement receptor type 2,Diet and food preferences,X20649.Liking for cucumber,36653,0.0260555117340578,0.0390356157888305,-0.05045429521205,0.102565318680166,0.504484419064239
CR2,Complement receptor type 2,Diet and food preferences,X20650.Liking for curry,36653,-0.143398570069744,0.0392643790391801,-0.220356752986537,-0.0664403871529512,0.000261727455098225
CR2,Complement receptor type 2,Diet and food preferences,X20651.Liking for dairy products,36653,0.0981406947782311,0.0395694663420584,0.0205845407477967,0.175696848808666,0.0131507083510764
CR2,Complement receptor type 2,Diet and food preferences,X20652.Liking for dark chocolate,36653,0.0252535632040943,0.0390570297041316,-0.0512982150160037,0.101805341424192,0.517921110304776
CR2,Complement receptor type 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36653,0.0654554960598341,0.0392281629983606,-0.0114317034169527,0.142342695536621,0.0952387144433264
CR2,Complement receptor type 2,Diet and food preferences,X20654.Liking for dried fruit,36653,0.014709703053364,0.0389831423273953,-0.0616972559083307,0.0911166620150587,0.705934637781008
CR2,Complement receptor type 2,Diet and food preferences,X20655.Liking for eggs,36653,0.0104263698587595,0.0398101548323219,-0.0676015336125914,0.0884542733301104,0.79340349657197
CR2,Complement receptor type 2,Diet and food preferences,X20656.Liking for exercising alone,36653,-0.0526812940068475,0.0386291154383933,-0.128394360266098,0.0230317722524033,0.172677593952012
CR2,Complement receptor type 2,Diet and food preferences,X20657.Liking for exercising with others,36653,-0.0498008759685372,0.0385237191114996,-0.125307365427076,0.0257056134900019,0.196140612238465
CR2,Complement receptor type 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36653,-0.100115641597274,0.039092580939627,-0.176737100238943,-0.0234941829556051,0.0104555685066497
CR2,Complement receptor type 2,Diet and food preferences,X20659.Liking for fatty foods,36653,-0.00387710010560325,0.0382940409090428,-0.0789334202873271,0.0711792200761206,0.919358085538791
CR2,Complement receptor type 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36653,-0.0600303928465872,0.0401426163521789,-0.138709920896858,0.0186491352036835,0.134842004004127
CR2,Complement receptor type 2,Diet and food preferences,X20661.Liking for fried chicken,36653,-0.01247320459065,0.0390002237246261,-0.0889136430909171,0.0639672339096171,0.749110116688642
CR2,Complement receptor type 2,Diet and food preferences,X20662.Liking for fried or battered fish,36653,-0.00464450712406105,0.0388574047602643,-0.0808050204541792,0.071516006206057,0.904860873957926
CR2,Complement receptor type 2,Diet and food preferences,X20663.Liking for fruit,36653,0.0363399500543963,0.0411911774572294,-0.0443947577617734,0.117074657870566,0.377680673201191
CR2,Complement receptor type 2,Diet and food preferences,X20664.Liking for garlic,36653,-0.0645068874428672,0.0393125101865558,-0.141559407408517,0.0125456325227822,0.10086260791015
CR2,Complement receptor type 2,Diet and food preferences,X20665.Liking for gherkins,36653,-0.0929665685593116,0.0384581376513121,-0.168344518355883,-0.0175886187627398,0.015656302762691
CR2,Complement receptor type 2,Diet and food preferences,X20666.Liking for globe artichoke,36653,-0.0747666330292104,0.0387965284308923,-0.150807828753759,0.00127456269533859,0.0539964266134015
CR2,Complement receptor type 2,Diet and food preferences,X20667.Liking for goat's cheese,36653,-0.105187760797977,0.0382589108017233,-0.180175225969355,-0.0302002956265996,0.00598439254956187
CR2,Complement receptor type 2,Diet and food preferences,X20668.Liking for going to a cafe,36653,0.0349651295619506,0.038982491246922,-0.0414405532820166,0.111370812405918,0.369775396794489
CR2,Complement receptor type 2,Diet and food preferences,X20669.Liking for going to the gym,36653,-0.0716951665665276,0.0385143379251496,-0.147183268899821,0.00379293576676562,0.0627073862800645
CR2,Complement receptor type 2,Diet and food preferences,X20670.Liking for going to the pub,36653,-0.167151999073032,0.0388879792737144,-0.243372438449513,-0.0909315596965524,1.74145844776981e-05
CR2,Complement receptor type 2,Diet and food preferences,X20671.Liking for grapefruit,36653,-0.0454808207405897,0.0389377427315055,-0.12179879649434,0.030837155013161,0.242825458347338
CR2,Complement receptor type 2,Diet and food preferences,X20672.Liking for green olives,36653,-0.0765256833126814,0.0386014702113255,-0.152184564926879,-0.000866801698483369,0.0474622911502868
CR2,Complement receptor type 2,Diet and food preferences,X20673.Liking for haddock,36653,-0.0420118017420689,0.0397290966603202,-0.119880831196297,0.0358572277121588,0.290334934618905
CR2,Complement receptor type 2,Diet and food preferences,X20674.Liking for ham,36653,0.0429170443728916,0.0395418147810527,-0.0345849125979717,0.120419001343755,0.277795435465759
CR2,Complement receptor type 2,Diet and food preferences,X20675.Liking for hard cheese,36653,0.0181689799668764,0.0398001256199924,-0.0598392662483087,0.0961772261820615,0.648038774955846
CR2,Complement receptor type 2,Diet and food preferences,X20676.Liking for herring,36653,-0.0243232992701566,0.0386033797439443,-0.0999859235682875,0.0513393250279742,0.528658755817874
CR2,Complement receptor type 2,Diet and food preferences,X20677.Liking for honey,36653,0.00157931801586092,0.0392946064573177,-0.0754381106404817,0.0785967466722036,0.967941272254945
CR2,Complement receptor type 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36653,-0.0453709610982827,0.0383586039735371,-0.120553824886415,0.02981190268985,0.236919200385332
CR2,Complement receptor type 2,Diet and food preferences,X20679.Liking for ice cream,36653,0.0768246010169058,0.0391128039367381,0.000163505300899161,0.153485696732913,0.0495435610801151
CR2,Complement receptor type 2,Diet and food preferences,X20680.Liking for jam,36653,0.0271017355628876,0.0386628657246346,-0.0486774812573962,0.102880952383171,0.483338356406444
CR2,Complement receptor type 2,Diet and food preferences,X20681.Liking for kiwi fruit,36653,0.0456736397557655,0.0387216071782183,-0.0302207103135423,0.121567989825073,0.238218562482811
CR2,Complement receptor type 2,Diet and food preferences,X20682.Liking for lager,36653,-0.078939245492552,0.0387050903415286,-0.154801222561948,-0.00307726842315596,0.0414322095705743
CR2,Complement receptor type 2,Diet and food preferences,X20683.Liking for lamb,36653,0.0133675549636835,0.0395697350182464,-0.0641891256720795,0.0909242355994465,0.735505613200346
CR2,Complement receptor type 2,Diet and food preferences,X20684.Liking for lemons,36653,-0.023652652278782,0.0386862369628903,-0.0994776767260469,0.052172372168483,0.540954013246002
CR2,Complement receptor type 2,Diet and food preferences,X20685.Liking for lentils or beans,36653,0.0136852720207888,0.0389121451666581,-0.062582532505861,0.0899530765474386,0.725074967471527
CR2,Complement receptor type 2,Diet and food preferences,X20686.Liking for liver,36653,0.0219739373194027,0.0389927292153045,-0.054451811942594,0.0983996865813995,0.573083380690917
CR2,Complement receptor type 2,Diet and food preferences,X20687.Liking for mackerel,36653,-0.0781740303959684,0.0386449047620014,-0.153918043729491,-0.00243001706244567,0.043118468971648
CR2,Complement receptor type 2,Diet and food preferences,X20688.Liking for marzipan,36653,-0.00426153783348868,0.0384620199779421,-0.0796470969902551,0.0711240213232777,0.911778822498112
CR2,Complement receptor type 2,Diet and food preferences,X20689.Liking for mayonnaise,36653,-0.037709834011299,0.0391085209704271,-0.114362535113336,0.038942867090738,0.334956731051885
CR2,Complement receptor type 2,Diet and food preferences,X20690.Liking for melon,36653,0.0174363934894386,0.0393770473926842,-0.0597426194002224,0.0946154063790997,0.657917958104216
CR2,Complement receptor type 2,Diet and food preferences,X20691.Liking for milk chocolate,36653,0.00692292014720496,0.0384714697276681,-0.0684811605190245,0.0823270008134344,0.857196779332928
CR2,Complement receptor type 2,Diet and food preferences,X20692.Liking for mushrooms,36653,-0.00503520573089455,0.0394660930316167,-0.0823887480728633,0.0723183366110742,0.89848211049611
CR2,Complement receptor type 2,Diet and food preferences,X20694.Liking for orange juice,36653,-0.0549075252807854,0.0388786315080813,-0.131109643036625,0.0212945924750538,0.157906129842822
CR2,Complement receptor type 2,Diet and food preferences,X20695.Liking for oranges,36653,-0.00168409939798081,0.0394858012264829,-0.0790762698018873,0.0757080710059256,0.965980990901646
CR2,Complement receptor type 2,Diet and food preferences,X20696.Liking for pasta,36653,0.0630597448709258,0.0390815016762428,-0.0135399984145101,0.139659488156362,0.10666547285746
CR2,Complement receptor type 2,Diet and food preferences,X20697.Liking for pears,36653,0.0698056915499019,0.0391732280057111,-0.00697383534129173,0.146585218441096,0.0747911097295427
CR2,Complement receptor type 2,Diet and food preferences,X20698.Liking for pizza,36653,0.0263047649107559,0.0388462105035535,-0.049833807676209,0.102443337497721,0.498329387507159
CR2,Complement receptor type 2,Diet and food preferences,X20699.Liking for plain yogurt,36653,-0.00612522398544588,0.0386090537935607,-0.0817989694208249,0.0695485214499332,0.87395070559084
CR2,Complement receptor type 2,Diet and food preferences,X20700.Liking for plums,36653,0.0590345641776268,0.0391760225181105,-0.0177504399578698,0.135819568313123,0.131874147349735
CR2,Complement receptor type 2,Diet and food preferences,X20701.Liking for pollock,36653,-0.0736168797481685,0.0382852413209246,-0.148655952737181,0.00142219324084372,0.0545338168157052
CR2,Complement receptor type 2,Diet and food preferences,X20702.Liking for pork chop,36653,0.0119055262202687,0.0393408524181266,-0.0652025445192594,0.0890135969597968,0.762183470246534
CR2,Complement receptor type 2,Diet and food preferences,X20703.Liking for porridge,36653,0.0345819524079914,0.0390942913965516,-0.0420428587292497,0.111206763545233,0.376410683498367
CR2,Complement receptor type 2,Diet and food preferences,X20704.Liking for potato crisps,36653,0.0173367250662575,0.0387129245842052,-0.0585406071187847,0.0932140572512998,0.654289515590689
CR2,Complement receptor type 2,Diet and food preferences,X20705.Liking for potatoes,36653,0.0237763885533724,0.0395386170748388,-0.0537193009133116,0.101272078020056,0.547626511933213
CR2,Complement receptor type 2,Diet and food preferences,X20706.Liking for prawns,36653,0.0114098300348732,0.0390326417614149,-0.0650941478175001,0.0879138078872464,0.770053264174154
CR2,Complement receptor type 2,Diet and food preferences,X20707.Liking for raw carrots,36653,0.0354361998548611,0.0388957281117427,-0.0407994272441545,0.111671826953877,0.362292986773909
CR2,Complement receptor type 2,Diet and food preferences,X20708.Liking for red meat,36653,0.0424879233490352,0.0397010407448706,-0.0353261165109113,0.120301963208982,0.284562883595457
CR2,Complement receptor type 2,Diet and food preferences,X20709.Liking for red wine,36653,-0.214106938430024,0.0393375265963922,-0.291208490558952,-0.137005386301095,5.39890015452622e-08
CR2,Complement receptor type 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36653,0.0411911771437504,0.0389653519590518,-0.0351809126959911,0.117563266983492,0.29048711450108
CR2,Complement receptor type 2,Diet and food preferences,X20711.Liking for roast chicken,36653,0.0689357693904853,0.0403651106409164,-0.0101798474657108,0.148051386246681,0.0877109710106662
CR2,Complement receptor type 2,Diet and food preferences,X20712.Liking for salad dressing,36653,-0.0505364856298185,0.038659369421115,-0.126308849695204,0.0252358784355669,0.191173746871473
CR2,Complement receptor type 2,Diet and food preferences,X20713.Liking for salad leaves,36653,0.00847155280963458,0.0390831501897002,-0.0681314215621779,0.085074527181447,0.828403092977167
CR2,Complement receptor type 2,Diet and food preferences,X20714.Liking for salami,36653,-0.0226670658483947,0.0385594118287064,-0.0982435130326593,0.0529093813358699,0.556650950733566
CR2,Complement receptor type 2,Diet and food preferences,X20715.Liking for salmon,36653,0.028207858085364,0.0397851957666428,-0.049771125617256,0.106186841787984,0.478342617751074
CR2,Complement receptor type 2,Diet and food preferences,X20716.Liking for salty foods,36653,0.0151315537482742,0.0383251545465576,-0.0599857491629786,0.0902488566595271,0.692985889160309
CR2,Complement receptor type 2,Diet and food preferences,X20717.Liking for salty pretzels,36653,-0.00985496053666342,0.038736952147311,-0.0857793867453929,0.0660694656720661,0.799187472078246
CR2,Complement receptor type 2,Diet and food preferences,X20718.Liking for sardines,36653,-0.0464965270077258,0.0385126642549776,-0.121981348947482,0.0289882949320303,0.22735025527452
CR2,Complement receptor type 2,Diet and food preferences,X20719.Liking for sausages (meat),36653,0.000423114916767548,0.039451140571733,-0.076901120603829,0.0777473504373641,0.991443089096377
CR2,Complement receptor type 2,Diet and food preferences,X20720.Liking for savoury biscuits,36653,-0.0604889003955301,0.0389345713367094,-0.136800660215481,0.0158228594244203,0.12031827783198
CR2,Complement receptor type 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36653,-0.0530129586700359,0.0384921144801832,-0.128457503051195,0.0224315857111231,0.168475746163896
CR2,Complement receptor type 2,Diet and food preferences,X20722.Liking for skimmed milk,36653,0.0232531601904568,0.0385799494012564,-0.0523635406360057,0.0988698610169193,0.54670760047995
CR2,Complement receptor type 2,Diet and food preferences,X20723.Liking for smoked fish,36653,-0.0314757937621496,0.0387905832465086,-0.107505336925307,0.0445537494010073,0.417143513549321
CR2,Complement receptor type 2,Diet and food preferences,X20724.Liking for soft cheese,36653,0.0216074295124649,0.0385923173750013,-0.0540335125425376,0.0972483715674673,0.575570467974443
CR2,Complement receptor type 2,Diet and food preferences,X20725.Liking for soy sauce,36653,-0.0733860679486885,0.0389375199828397,-0.149703607115054,0.0029314712176773,0.0595045543280405
CR2,Complement receptor type 2,Diet and food preferences,X20726.Liking for soya milk,36653,0.0267250540840107,0.03918248100156,-0.0500726086790469,0.103522716847068,0.495216598653493
CR2,Complement receptor type 2,Diet and food preferences,X20727.Liking for spicy foods,36653,-0.151236059757473,0.0387770534084551,-0.227239084438045,-0.0752330350769008,9.69183126728266e-05
CR2,Complement receptor type 2,Diet and food preferences,X20728.Liking for spinach,36653,-0.0400628542020292,0.0389333751513883,-0.11637226949875,0.0362465610946918,0.30350565164453
CR2,Complement receptor type 2,Diet and food preferences,X20729.Liking for spirits,36653,-0.121101110738683,0.0385147480023154,-0.196590016823221,-0.0456122046541447,0.00167102609916125
CR2,Complement receptor type 2,Diet and food preferences,X20730.Liking for strawberries,36653,0.0369522774477204,0.0403067671801062,-0.0420489862252877,0.115953541120728,0.359287506972786
CR2,Complement receptor type 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36653,0.0729705184657203,0.0390876058486317,-0.0036411889975978,0.149582225929038,0.0619595269566728
CR2,Complement receptor type 2,Diet and food preferences,X20732.Liking for sweet foods,36653,0.0390175847023693,0.0385514077647868,-0.0365431745166129,0.114578343921351,0.311524343437949
CR2,Complement receptor type 2,Diet and food preferences,X20733.Liking for taking the stairs,36653,-0.0508900149367107,0.0392537115196948,-0.127827289515312,0.026047259641891,0.194861715383045
CR2,Complement receptor type 2,Diet and food preferences,X20734.Liking for tea with sugar,36653,0.0105340426929332,0.0424451575126628,-0.0726584660318858,0.0937265514177522,0.804001411293769
CR2,Complement receptor type 2,Diet and food preferences,X20735.Liking for tea without sugar,36653,-0.0259981863746615,0.0396311708193638,-0.103675281180615,0.0516789084312916,0.511840641373334
CR2,Complement receptor type 2,Diet and food preferences,X20736.Liking for tomato ketchup,36653,0.00413966479613163,0.0388315870505748,-0.0719702458229949,0.0802495754152582,0.915104530892423
CR2,Complement receptor type 2,Diet and food preferences,X20737.Liking for tinned tuna,36653,-0.00879067391918365,0.0387808981228308,-0.084801234239932,0.0672198864015647,0.820681950589192
CR2,Complement receptor type 2,Diet and food preferences,X20738.Liking for turnip (white),36653,-0.0703983743090749,0.0389547275819983,-0.146749640369792,0.00595289175164165,0.0707708851518847
CR2,Complement receptor type 2,Diet and food preferences,X20739.Liking for vegetables,36653,0.0253774106980811,0.0408355482738767,-0.0546602639187173,0.105415085314879,0.534318628510001
CR2,Complement receptor type 2,Diet and food preferences,X20740.Liking for vinegar,36653,0.00565594373293307,0.0391737238383666,-0.0711245549902654,0.0824364424561315,0.885203189786037
CR2,Complement receptor type 2,Diet and food preferences,X20741.Liking for watching television,36653,0.077232521749415,0.0390422497877963,0.000709712165334192,0.153755331333496,0.0479426895049097
CR2,Complement receptor type 2,Diet and food preferences,X20742.Liking for whisky,36653,-0.115348878479857,0.0386277370177948,-0.191059243034735,-0.0396385139249792,0.00283349172009026
CR2,Complement receptor type 2,Diet and food preferences,X20743.Liking for white bread,36653,0.0576983106308444,0.038790291145185,-0.0183306600137182,0.133727281275407,0.136937290951529
CR2,Complement receptor type 2,Diet and food preferences,X20744.Liking for white rice,36653,0.00319861387955927,0.0393767449289485,-0.0739798061811797,0.0803770339402982,0.935260236902831
CR2,Complement receptor type 2,Diet and food preferences,X20745.Liking for white wine,36653,-0.0851019679650425,0.0384989020066588,-0.160559815898094,-0.00964412003199122,0.0270982575078364
CR2,Complement receptor type 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36653,0.0344613632071087,0.0392006441441236,-0.0423718993153736,0.111294625729591,0.379372253003359
CR2,Complement receptor type 2,Diet and food preferences,X20747.Liking for whole milk,36653,0.0677531721031279,0.0384317673616524,-0.00757309192571086,0.143079436131967,0.0779473807022838
CR2,Complement receptor type 2,Diet and food preferences,X20748.Liking for wholemeal bread,36653,-0.0326614954675943,0.0400418252766708,-0.111143473009869,0.0458204820746805,0.414704768775447
CR2,Complement receptor type 2,Diet and food preferences,X20749.Liking for working up a sweat,36653,-0.162451717971952,0.0392887063776301,-0.239457582472107,-0.0854458534717965,3.58843771417478e-05
CR2,Complement receptor type 2,Physical measures,X21001.Body mass index (BMI),52281,-0.0401843901667526,0.0180585448252189,-0.0755791380241816,-0.00478964230932361,0.0260752783633642
CR2,Complement receptor type 2,Physical measures,X21002.Weight,52313,0.0223272271974925,0.00870296915043294,0.0052694076626439,0.039385046732341,0.0103096326861122
CR2,Complement receptor type 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36552,0.00374736214671752,0.00660674860248212,-0.00920186511414744,0.0166965894075825,0.570592844355148
CR2,Complement receptor type 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36412,0.0825526501476915,0.0430682582957665,-0.00186113611201097,0.166966436407394,0.0553015424425417
CR2,Complement receptor type 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36414,-0.0771862389148461,0.0435460083830142,-0.162536415345554,0.00816393751586175,0.0763469879373199
CR2,Complement receptor type 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36415,-0.0112807668024949,0.0421805658038391,-0.0939546757780195,0.0713931421730297,0.789137532951848
CR2,Complement receptor type 2,Health and medical history,X21040.Satisfaction with bowel habits,36387,0.0614494959331321,0.0393030836794467,-0.0155845480785836,0.138483539944848,0.117980953073995
CR2,Complement receptor type 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36388,0.128633848174149,0.0429903802700698,0.0443727028448121,0.212894993503486,0.00277885511084264
CR2,Complement receptor type 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36383,-0.0128463493655237,0.0422724166863618,-0.0957002860707929,0.0700075873397455,0.761216493258067
CR2,Complement receptor type 2,Health and medical history,X21043.Least number of times bowels opened per week,36349,-0.00199995766078184,0.0418204676959246,-0.0839680743447941,0.0799681590232304,0.961858968781152
CR2,Complement receptor type 2,Health and medical history,X21044.Average number of times bowels opened per day,36360,0.0257208587645622,0.0464454622994307,-0.0653122473423219,0.116753964871446,0.579741106645167
CR2,Complement receptor type 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36421,-0.00975593261140572,0.0428785520132463,-0.0937978945573685,0.0742860293345571,0.82002165993557
CR2,Complement receptor type 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36417,0.0607073898545499,0.042741303610749,-0.0230655652225182,0.144480344931618,0.155547201809114
CR2,Complement receptor type 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36419,0.0378455805523912,0.0495299541566822,-0.0592331295947059,0.134924290699488,0.444833808882242
CR2,Complement receptor type 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36419,0.00753296190613734,0.0619981066933995,-0.113983327212926,0.1290492510252,0.903295685313867
CR2,Complement receptor type 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36419,-0.0477087325402398,0.0519590954637748,-0.149548559649238,0.0541310945687588,0.358543591511045
CR2,Complement receptor type 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36417,-0.211012153435415,0.124813264073775,-0.455646151020014,0.0336218441491837,0.0909487344488489
CR2,Complement receptor type 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36421,0.0566222217246683,0.0529204034168268,-0.0471017689723123,0.160346212421649,0.28467453154822
CR2,Complement receptor type 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36418,-0.0687867291351269,0.0484311255918891,-0.16371173529523,0.0261382770249758,0.155560234513267
CR2,Complement receptor type 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36274,0.0633135561000535,0.048064427212819,-0.0308927212370717,0.157519833437179,0.187789372373039
CR2,Complement receptor type 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36415,-0.101917578590152,0.0435857324529091,-0.187345614197854,-0.0164895429824502,0.0193955167139668
CR2,Complement receptor type 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36420,0.00314563899013182,0.0745159923271525,-0.142905705971087,0.149196983951351,0.966328956513989
CR2,Complement receptor type 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36421,-0.0905772776336257,0.0428053013180684,-0.17447566821704,-0.00667888705021163,0.0343738202289069
CR2,Complement receptor type 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36420,-0.102796077457911,0.0425456109272955,-0.18618547487541,-0.0194066800404115,0.0157088676267965
CR2,Complement receptor type 2,Working and living environment,X21100.Water hardness (USGS classification),52148,0.0181886993280105,0.0235412074058855,-0.027952067187525,0.0643294658435461,0.439747725450058
CR2,Complement receptor type 2,Lifestyle factors,X2139.Age first had sexual intercourse,49312,0.01994799083377,0.00357168868645601,0.0129474810083162,0.0269485006592238,2.36592182451269e-08
CR2,Complement receptor type 2,Health and medical history,X2149.Lifetime number of sexual partners,47619,-0.127943859026407,0.0268867136204146,-0.18064181772242,-0.0752459003303944,1.96345733187299e-06
CR2,Complement receptor type 2,Physical activities,X22032.IPAQ activity group,48499,-0.0719029819000818,0.0257090733209222,-0.122292765609089,-0.0215131981910743,0.00516619593659525
CR2,Complement receptor type 2,Physical activities,X22033.Summed days activity,48906,-0.0149262621577018,0.00352805497368486,-0.0218412499061241,-0.0080112744092795,2.33951089606501e-05
CR2,Complement receptor type 2,Physical activities,X22034.Summed minutes activity,48499,-0.0115969155156141,0.00356843679644066,-0.0185910516366378,-0.00460277939459041,0.00115654090918698
CR2,Complement receptor type 2,Physical activities,X22037.MET minutes per week for walking,47775,-0.007161031241448,0.00365208606673721,-0.0143191199322529,-2.9425506430647e-06,0.049916144589673
CR2,Complement receptor type 2,Physical activities,X22038.MET minutes per week for moderate activity,48499,-0.00894746927541051,0.00361966954496479,-0.0160420215835415,-0.00185291696727953,0.0134479280697421
CR2,Complement receptor type 2,Physical activities,X22039.MET minutes per week for vigorous activity,48499,-0.109505335793347,0.0255991443730855,-0.159679658764595,-0.0593310128220998,1.89719540314875e-05
CR2,Complement receptor type 2,Physical activities,X22040.Summed MET minutes per week for all activity,47775,-0.012207081732027,0.00362318543738432,-0.0193085251893003,-0.00510563827475377,0.000755468898073257
CR2,Complement receptor type 2,Eye measures,X2217.Age started wearing glasses or contact lenses,48563,0.00163690116482166,0.00372060920760017,-0.00565549288207468,0.00892929521171799,0.659974357403294
CR2,Complement receptor type 2,Working and living environment,X22501.Year ended full time education,34200,-0.017696100723144,0.0165571566278441,-0.0501481277137183,0.0147559262674304,0.285210992219373
CR2,Complement receptor type 2,Lifestyle factors,X22506.Tobacco smoking,34162,-0.100430919764572,0.094865456746404,-0.286367214987524,0.0855053754583796,0.289797494019786
CR2,Complement receptor type 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50923,-0.301129194435222,0.0739854720966736,-0.446140719744703,-0.156117669125742,4.71521517382523e-05
CR2,Complement receptor type 2,Physical measures,X23098.Weight,51866,0.0232073708673446,0.00878467709949632,0.00598940375233182,0.0404253379823574,0.00825215892477079
CR2,Complement receptor type 2,Physical measures,X23099.Body fat percentage,51835,0.0135839626500069,0.00784115731411403,-0.00178470568565664,0.0289526309856704,0.083216960539277
CR2,Complement receptor type 2,Physical measures,X23100.Whole body fat mass,51794,0.019765108389361,0.00783832726054527,0.00440198695869225,0.0351282298200297,0.0116889631437822
CR2,Complement receptor type 2,Physical measures,X23101.Whole body fat-free mass,51861,0.0113923849287752,0.00758385185601818,-0.00347196470902044,0.0262567345665708,0.133061671957826
CR2,Complement receptor type 2,Physical measures,X23102.Whole body water mass,51866,0.0119344806933229,0.00756594176421866,-0.0028947651645457,0.0267637265511915,0.114718200361361
CR2,Complement receptor type 2,Physical measures,X23104.Body mass index (BMI),51866,-0.0354225179087956,0.0178743281639458,-0.0704562011101294,-0.00038883470746183,0.0475185510607309
CR2,Complement receptor type 2,Physical measures,X23105.Basal metabolic rate,51866,0.0140991147547561,0.00788055507587832,-0.00134677319396536,0.0295450027034776,0.0736114367576666
CR2,Complement receptor type 2,Physical measures,X23106.Impedance of whole body,51866,0.0152900603276077,0.00620400653139599,0.0031302075260716,0.0274499131291439,0.0137258622646529
CR2,Complement receptor type 2,Physical measures,X23107.Impedance of leg (right),51866,0.0143813213891479,0.0050152586685467,0.00455141439879634,0.0242112283794994,0.00414082912161557
CR2,Complement receptor type 2,Physical measures,X23108.Impedance of leg (left),51866,0.0108324661916805,0.00499867287007797,0.00103506736632771,0.0206298650170334,0.0302397491044737
CR2,Complement receptor type 2,Physical measures,X23109.Impedance of arm (right),51866,0.0113033365439719,0.00614320609900279,-0.000737347410073553,0.0233440204980174,0.0657848555125949
CR2,Complement receptor type 2,Physical measures,X23110.Impedance of arm (left),51866,0.0144558749597018,0.00613796880501029,0.00242545610188166,0.026486293817522,0.0185231797846957
CR2,Complement receptor type 2,Physical measures,X23111.Leg fat percentage (right),51866,0.00799981623414448,0.00798055161124954,-0.00764206492390463,0.0236416973921936,0.316154134344891
CR2,Complement receptor type 2,Physical measures,X23112.Leg fat mass (right),51866,0.0239239417713523,0.00859711322833309,0.00707359984381948,0.0407742836988852,0.00539374799027099
CR2,Complement receptor type 2,Physical measures,X23113.Leg fat-free mass (right),51865,0.0112365204954993,0.00833492454323491,-0.00509993160924111,0.0275729726002397,0.177631293671116
CR2,Complement receptor type 2,Physical measures,X23114.Leg predicted mass (right),51865,0.0115110687694526,0.00839622910848314,-0.00494554028317438,0.0279676778220795,0.170394170946065
CR2,Complement receptor type 2,Physical measures,X23115.Leg fat percentage (left),51865,0.000452056964097666,0.00835650046287833,-0.0159266839431439,0.0168307978713392,0.956858789413667
CR2,Complement receptor type 2,Physical measures,X23116.Leg fat mass (left),51865,0.019597358630935,0.00910737529178388,0.00174690305903855,0.0374478142028314,0.0314224296065519
CR2,Complement receptor type 2,Physical measures,X23117.Leg fat-free mass (left),51864,0.0191226276422105,0.00906563451392667,0.00135398399491418,0.0368912712895067,0.0349247370101798
CR2,Complement receptor type 2,Physical measures,X23118.Leg predicted mass (left),51864,0.0189543604607293,0.00913726704344197,0.00104531705558308,0.0368634038658756,0.0380530084445135
CR2,Complement receptor type 2,Physical measures,X23119.Arm fat percentage (right),51864,0.00632798233713155,0.00880714139986456,-0.010934014806603,0.0235899794808661,0.472452677686233
CR2,Complement receptor type 2,Physical measures,X23120.Arm fat mass (right),51863,0.0197723368045327,0.00962376335738022,0.000909760624067436,0.0386349129849979,0.0399353044235225
CR2,Complement receptor type 2,Physical measures,X23121.Arm fat-free mass (right),51862,0.0145749082924192,0.00832427518317049,-0.00174067106659493,0.0308904876514334,0.0799776650836707
CR2,Complement receptor type 2,Physical measures,X23122.Arm predicted mass (right),51862,0.0145282507260882,0.00836290488713809,-0.00186304285270244,0.0309195443048789,0.0823606304473527
CR2,Complement receptor type 2,Physical measures,X23123.Arm fat percentage (left),51860,0.0109756289001089,0.00829586584331976,-0.00528426815279783,0.0272355259530156,0.185840430938572
CR2,Complement receptor type 2,Physical measures,X23124.Arm fat mass (left),51860,0.0269407657306384,0.00924635475025068,0.00881791042014708,0.0450636210411298,0.00357554893358753
CR2,Complement receptor type 2,Physical measures,X23125.Arm fat-free mass (left),51856,0.0105173231130745,0.00758214198211145,-0.00434367517186398,0.0253783213980129,0.165419178336774
CR2,Complement receptor type 2,Physical measures,X23126.Arm predicted mass (left),51855,0.0105368605450934,0.00762600809558314,-0.00441011532224959,0.0254838364124363,0.1670768997988
CR2,Complement receptor type 2,Physical measures,X23127.Trunk fat percentage,51853,0.0115664157641914,0.00663964978866453,-0.00144729782159105,0.0245801293499739,0.0815178230229197
CR2,Complement receptor type 2,Physical measures,X23128.Trunk fat mass,51853,0.0163341069264701,0.00699608652451643,0.00262177733841795,0.0300464365145223,0.0195649949398192
CR2,Complement receptor type 2,Physical measures,X23129.Trunk fat-free mass,51852,0.00705127799617684,0.00657576510783433,-0.00583722161517844,0.0199397776075321,0.28359062696725
CR2,Complement receptor type 2,Physical measures,X23130.Trunk predicted mass,51850,0.00755942283915669,0.00657103502349028,-0.00531980580688425,0.0204386514851976,0.249984467163449
CR2,Complement receptor type 2,NMR metabolomics,X23400.Total Cholesterol,42217,-0.0423260211215829,0.00468522164201758,-0.0515090555399373,-0.0331429867032284,1.87601709417221e-19
CR2,Complement receptor type 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42217,-0.0228415099655526,0.00458806195666529,-0.0318341114006165,-0.0138489085304886,6.48743285052959e-07
CR2,Complement receptor type 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42217,-0.0134126439458491,0.00461511696673839,-0.0224582732006564,-0.00436701469104188,0.00366388642113122
CR2,Complement receptor type 2,NMR metabolomics,X23403.VLDL Cholesterol,42217,0.0121642152852877,0.00475923972904481,0.00283610541635986,0.0214923251542155,0.0106016393143154
CR2,Complement receptor type 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,42217,-0.0325836311196062,0.00457421124564429,-0.041549085161069,-0.0236181770781434,1.10637988520514e-12
CR2,Complement receptor type 2,NMR metabolomics,X23405.LDL Cholesterol,42217,-0.0299450589419931,0.00455479952510793,-0.0388724660112047,-0.0210176518727816,5.06311581055276e-11
CR2,Complement receptor type 2,NMR metabolomics,X23406.HDL Cholesterol,42217,-0.0842880701497492,0.00514643762583213,-0.0943750878963802,-0.0742010524031183,1.02243356486607e-59
CR2,Complement receptor type 2,NMR metabolomics,X23407.Total Triglycerides,42217,0.0285640239437947,0.00483124094590977,0.0190947916898116,0.0380332561977779,3.4532064123115e-09
CR2,Complement receptor type 2,NMR metabolomics,X23408.Triglycerides in VLDL,42217,0.0299995016080338,0.00490336592642133,0.020388904392248,0.0396100988238196,9.72654455996581e-10
CR2,Complement receptor type 2,NMR metabolomics,X23409.Triglycerides in LDL,42217,0.0147080898368779,0.00455417909358354,0.0057818988134542,0.0236342808603017,0.00124265842955535
CR2,Complement receptor type 2,NMR metabolomics,X23410.Triglycerides in HDL,42217,0.0227616406038284,0.00472936102630121,0.0134920929922781,0.0320311882153788,1.50400230428093e-06
CR2,Complement receptor type 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42217,-0.0411759570626464,0.00470985923274349,-0.0504072811588237,-0.0319446329664692,2.54420832390709e-18
CR2,Complement receptor type 2,NMR metabolomics,X23412.Phospholipids in VLDL,42217,0.0231500316141756,0.00480577283469931,0.013730716858165,0.0325693463701862,1.4720644969828e-06
CR2,Complement receptor type 2,NMR metabolomics,X23413.Phospholipids in LDL,42217,-0.0285833146473059,0.00457101504804603,-0.0375425041414761,-0.0196241251531356,4.14230452390305e-10
CR2,Complement receptor type 2,NMR metabolomics,X23414.Phospholipids in HDL,42217,-0.0632462139863449,0.00495172811043468,-0.0729516010827969,-0.0535408268898929,3.81195134326124e-37
CR2,Complement receptor type 2,NMR metabolomics,X23415.Total Esterified Cholesterol,42217,-0.0467952233557475,0.00470734431907171,-0.056021618221128,-0.0375688284903669,3.31496818846354e-23
CR2,Complement receptor type 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42217,0.00730380208540944,0.00473372811964284,-0.00197430502909053,0.0165819091999094,0.122871461984538
CR2,Complement receptor type 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42217,-0.026743226040625,0.00455547420280885,-0.0356719554781304,-0.0178144966031197,4.44414637203687e-09
CR2,Complement receptor type 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42217,-0.0869817306104178,0.00514714313807056,-0.0970701311610361,-0.0768933300597995,2.02335883434804e-63
CR2,Complement receptor type 2,NMR metabolomics,X23419.Total Free Cholesterol,42217,-0.0306978317336812,0.00463440124613218,-0.0397812581761002,-0.0216144052912621,3.62968439541705e-11
CR2,Complement receptor type 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,42217,0.0181077010246239,0.00478972464059596,0.00871984072905578,0.027495561320192,0.000157162612626313
CR2,Complement receptor type 2,NMR metabolomics,X23421.Free Cholesterol in LDL,42217,-0.0376739244643461,0.00457338307342747,-0.0466377552882639,-0.0287100936404283,1.91539993145928e-16
CR2,Complement receptor type 2,NMR metabolomics,X23422.Free Cholesterol in HDL,42217,-0.069968546030744,0.00513288032631932,-0.0800289914703298,-0.0599081005911581,4.91348280210735e-42
CR2,Complement receptor type 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42217,-0.0242581681943858,0.00453456309785057,-0.0331459118661729,-0.0153704245225986,8.95675531173948e-08
CR2,Complement receptor type 2,NMR metabolomics,X23424.Total Lipids in VLDL,42217,0.0254379918896226,0.00480988071793491,0.0160106256824702,0.034865358096775,1.25098397846846e-07
CR2,Complement receptor type 2,NMR metabolomics,X23425.Total Lipids in LDL,42217,-0.0274257691244992,0.00455646788253782,-0.0363564461742733,-0.018495092074725,1.79912112663244e-09
CR2,Complement receptor type 2,NMR metabolomics,X23426.Total Lipids in HDL,42217,-0.0697616414860509,0.00502639712874724,-0.0796133798583955,-0.0599099031137063,1.67810443280754e-43
CR2,Complement receptor type 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42217,-0.0720398750881745,0.00476507946783119,-0.0813794308451237,-0.0627003193312254,3.19382087209197e-51
CR2,Complement receptor type 2,NMR metabolomics,X23428.Concentration of VLDL Particles,42217,0.0176677812775659,0.00474733152762355,0.00836301148342375,0.0269725510717081,0.000198742540509322
CR2,Complement receptor type 2,NMR metabolomics,X23429.Concentration of LDL Particles,42217,-0.0108759095833533,0.00458507315875415,-0.0198626529745114,-0.00188916619219514,0.017704697868939
CR2,Complement receptor type 2,NMR metabolomics,X23430.Concentration of HDL Particles,42217,-0.0741117105063234,0.00476661020153246,-0.0834542665013271,-0.0647691545113198,4.77456861085563e-54
CR2,Complement receptor type 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42217,0.032231619509696,0.00497539895325138,0.0224798375613233,0.0419834014580687,9.60148369466569e-11
CR2,Complement receptor type 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,42217,-0.0280220473941704,0.00471559171324544,-0.0372646071521314,-0.0187794876362093,2.87697325540925e-09
CR2,Complement receptor type 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,42217,-0.0402844703172025,0.00519763546225966,-0.0504718358232314,-0.0300971048111736,9.796642276751e-15
CR2,Complement receptor type 2,NMR metabolomics,X23434.Phosphoglycerides,42208,-0.0411187346204907,0.00472115395950481,-0.0503721963811201,-0.0318652728598612,3.40153951681693e-18
CR2,Complement receptor type 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42208,0.0581182557943143,0.0050735009841149,0.0481741938654491,0.0680623177231795,3.04496617283637e-30
CR2,Complement receptor type 2,NMR metabolomics,X23436.Total Cholines,42208,-0.0462660311570231,0.00479753625647773,-0.0556692022197195,-0.0368628600943268,6.14309209817299e-22
CR2,Complement receptor type 2,NMR metabolomics,X23437.Phosphatidylcholines,42208,-0.045667973430235,0.00481572397753692,-0.0551067924262074,-0.0362291544342627,2.87140803734717e-21
CR2,Complement receptor type 2,NMR metabolomics,X23438.Sphingomyelins,42208,-0.0555224825118399,0.00483548955921822,-0.0650000420479076,-0.0460449229757722,2.23478300285346e-30
CR2,Complement receptor type 2,NMR metabolomics,X23439.Apolipoprotein B,42217,-0.00990443295530816,0.00460032508837376,-0.0189210701285207,-0.000887795782095592,0.03133733048584
CR2,Complement receptor type 2,NMR metabolomics,X23440.Apolipoprotein A1,42217,-0.0703815390772551,0.00491726660422198,-0.0800193816215302,-0.06074369653298,3.91355332768048e-46
CR2,Complement receptor type 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42217,0.0276197097970384,0.00469376990750167,0.0184199207783352,0.0368194988157417,4.09052458609063e-09
CR2,Complement receptor type 2,NMR metabolomics,X23442.Total Fatty Acids,42208,-0.00659784858091658,0.00442324163583267,-0.0152674021871486,0.00207170502531545,0.135818835954805
CR2,Complement receptor type 2,NMR metabolomics,X23443.Degree of Unsaturation,42208,-0.0248384171380938,0.0047873179575216,-0.0342215603348361,-0.0154552739413514,2.15181904028832e-07
CR2,Complement receptor type 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,42208,-0.00362196550190758,0.00464755461662983,-0.012731172550502,0.00548724154668688,0.435800577022185
CR2,Complement receptor type 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,42208,-0.0221747426246745,0.00457294563032941,-0.0311377160601201,-0.0132117691892288,1.25384175729771e-06
CR2,Complement receptor type 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42208,-0.0202891469862601,0.00459494367042155,-0.0292952365802864,-0.0112830573922339,1.01536017001755e-05
CR2,Complement receptor type 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42208,0.00827596806278729,0.00450533804855291,-0.000554494512376416,0.017106430637951,0.0662427648482678
CR2,Complement receptor type 2,NMR metabolomics,X23448.Saturated Fatty Acids,42208,-0.00879126201146152,0.00436484830770243,-0.0173463646945583,-0.000236159328364769,0.0440181705516037
CR2,Complement receptor type 2,NMR metabolomics,X23449.Linoleic Acid,42208,-0.0133549997344183,0.00456566061408895,-0.0223036945380326,-0.00440630493080395,0.00344917487240069
CR2,Complement receptor type 2,NMR metabolomics,X23450.Docosahexaenoic Acid,42208,-0.0257767508513946,0.00460654320132307,-0.0348055755259878,-0.0167479261768014,2.23998081503342e-08
CR2,Complement receptor type 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42208,-0.000791056547063352,0.00466108816715117,-0.00992678935467965,0.00834467626055295,0.865236804965322
CR2,Complement receptor type 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42208,-0.0157281606138735,0.00457809983424444,-0.0247012362889926,-0.00675508493875437,0.000593179827220172
CR2,Complement receptor type 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42208,-0.0159882739493037,0.0046887686129648,-0.0251782604307147,-0.00679828746789271,0.000651732275763215
CR2,Complement receptor type 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42208,0.0392633154560507,0.00491049851726326,0.0296387383622147,0.0488878925498867,1.3907626382226e-15
CR2,Complement receptor type 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42208,-0.011713284325952,0.00426944046839925,-0.0200813876440145,-0.00334518100788948,0.00608644143803297
CR2,Complement receptor type 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42208,-0.00823611524886694,0.00469072968269773,-0.0174299454269545,0.000957714929220616,0.079140250466345
CR2,Complement receptor type 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42208,-0.0206791878752527,0.00456385598997407,-0.0296243456156019,-0.0117340301349036,5.91829928542146e-06
CR2,Complement receptor type 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42208,-0.0304374022574971,0.00487018166901472,-0.0399829583287659,-0.0208918461862282,4.23381819935467e-10
CR2,Complement receptor type 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42208,-0.00533051357563146,0.00460173857669528,-0.0143499211859542,0.00368889403469129,0.246733612214291
CR2,Complement receptor type 2,NMR metabolomics,X23460.Alanine,42214,0.0151650847222246,0.00458634048329481,0.00617585737496678,0.0241543120694824,0.000946880875403441
CR2,Complement receptor type 2,NMR metabolomics,X23461.Glutamine,42170,-0.0173037715024375,0.00452411369534472,-0.0261710343453131,-0.00843650865956181,0.000131471113860295
CR2,Complement receptor type 2,NMR metabolomics,X23462.Glycine,42203,-0.00330937486574219,0.00547693717504545,-0.0140441717288313,0.00742542199734689,0.545695339246955
CR2,Complement receptor type 2,NMR metabolomics,X23463.Histidine,42200,-0.00247276758914856,0.00455144779788373,-0.0113936052730007,0.00644807009470354,0.586937311011041
CR2,Complement receptor type 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42207,0.0117576201275759,0.00509804502119511,0.00176545188603351,0.0217497883691183,0.0211088399607241
CR2,Complement receptor type 2,NMR metabolomics,X23465.Isoleucine,42215,0.00795991237860972,0.00492102986356582,-0.00168530615397929,0.0176051309111987,0.105787137222668
CR2,Complement receptor type 2,NMR metabolomics,X23466.Leucine,42215,0.00491849077427586,0.00505785631917631,-0.0049949076113097,0.0148318891598614,0.330846127624879
CR2,Complement receptor type 2,NMR metabolomics,X23467.Valine,42207,0.0159715744951326,0.00506457679652146,0.0060450039739505,0.0258981450163146,0.00161628773828934
CR2,Complement receptor type 2,NMR metabolomics,X23468.Phenylalanine,42209,0.0156225988641564,0.00468647515437145,0.00643710756158839,0.0248080901667245,0.000859741001308255
CR2,Complement receptor type 2,NMR metabolomics,X23469.Tyrosine,42203,0.00809522845085649,0.00484518311067077,-0.00140133044605821,0.0175917873477712,0.0947884131398356
CR2,Complement receptor type 2,NMR metabolomics,X23470.Glucose,42195,0.0186490207197163,0.00442732388105243,0.00997146591285358,0.0273265755265791,2.54462348976462e-05
CR2,Complement receptor type 2,NMR metabolomics,X23471.Lactate,42196,0.00744938835337932,0.00465903476387595,-0.00168231978381754,0.0165810964905762,0.109863309930322
CR2,Complement receptor type 2,NMR metabolomics,X23472.Pyruvate,42168,-0.00936015228418246,0.00448151130304531,-0.0181439144381513,-0.000576390130213659,0.0367609749911223
CR2,Complement receptor type 2,NMR metabolomics,X23473.Citrate,42214,0.0189754278217498,0.00464156316780116,0.0098779640128595,0.0280728916306401,4.37315401442176e-05
CR2,Complement receptor type 2,NMR metabolomics,X23474.3-Hydroxybutyrate,41937,-0.0231230646498635,0.00512062717264304,-0.0331594939082439,-0.0130866353914831,6.3657882973065e-06
CR2,Complement receptor type 2,NMR metabolomics,X23475.Acetate,42205,0.00824258417136465,0.00441719240687898,-0.000415112946118151,0.0169002812888474,0.0620596000634516
CR2,Complement receptor type 2,NMR metabolomics,X23476.Acetoacetate,42216,-0.0212678894095559,0.00464316987304626,-0.0303685023607265,-0.0121672764583852,4.68052335167014e-06
CR2,Complement receptor type 2,NMR metabolomics,X23477.Acetone,42216,-0.025461862278978,0.00461339374104238,-0.0345041140114211,-0.0164196105465349,3.46933884062522e-08
CR2,Complement receptor type 2,NMR metabolomics,X23478.Creatinine,41954,0.0414527115710442,0.00555422100859006,0.0305664383942077,0.0523389847478808,8.96116079481765e-14
CR2,Complement receptor type 2,NMR metabolomics,X23479.Albumin,42215,0.00868614031329974,0.00459278090272483,-0.000315710256040928,0.0176879908826404,0.0586109252053872
CR2,Complement receptor type 2,NMR metabolomics,X23480.Glycoprotein Acetyls,42217,0.0104289345428697,0.0047846095648337,0.00105109979579569,0.0198067692899438,0.0292980026739728
CR2,Complement receptor type 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42217,0.0360113852767056,0.00485607046303585,0.0264934871691553,0.0455292833842558,1.28083884473484e-13
CR2,Complement receptor type 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42217,0.0342494909911115,0.00482934740326966,0.024783970080703,0.0437150119015201,1.387589814138e-12
CR2,Complement receptor type 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42217,0.0381997905679401,0.00498613434226803,0.0284269672570947,0.0479726138787854,1.96608663489361e-14
CR2,Complement receptor type 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42217,0.0352137144634259,0.00490604504934684,0.0255978661667061,0.0448295627601457,7.46093669762361e-13
CR2,Complement receptor type 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42217,0.0349367531761232,0.00490622970870618,0.0253205429470591,0.0445529634051873,1.12604728723037e-12
CR2,Complement receptor type 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42217,0.0351101792612578,0.00487365297617359,0.0255578194279575,0.044662539094558,6.15082744259485e-13
CR2,Complement receptor type 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42217,0.0316395012590401,0.00473557753768216,0.022357769285183,0.0409212332328971,2.46146266928242e-11
CR2,Complement receptor type 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42217,0.0345345871362657,0.00505927908543151,0.02461840012882,0.0444507741437115,9.10176146775862e-12
CR2,Complement receptor type 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42217,0.033754366115445,0.00502350708501507,0.0239082922288155,0.0436004400020745,1.89880141874849e-11
CR2,Complement receptor type 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42217,0.03573920434501,0.0050202215360952,0.0258995701342634,0.0455788385557566,1.14118262287513e-12
CR2,Complement receptor type 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42217,0.0305441281026408,0.00499288805675313,0.0207580675114046,0.0403301886938769,9.76419032167868e-10
CR2,Complement receptor type 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42217,0.0252948476685105,0.00498945285368644,0.0155155200752851,0.035074175261736,4.03750619730334e-07
CR2,Complement receptor type 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42217,0.0345731411805398,0.00497858677607472,0.0248151110994333,0.0443311712616462,3.97395453713059e-12
CR2,Complement receptor type 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42217,0.0328683907708955,0.00503770576651467,0.0229944874685267,0.0427422940732642,7.06523056673383e-11
CR2,Complement receptor type 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42217,0.0312483525642202,0.00498748039561579,0.0214728909888132,0.0410238141396271,3.83166700851327e-10
CR2,Complement receptor type 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,42217,0.0291680892667346,0.00497517913150144,0.0194167381689918,0.0389194403644774,4.65888976619517e-09
CR2,Complement receptor type 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,42217,0.0346996423428966,0.00506807082036521,0.0247662235349808,0.0446330611508124,7.88021995855044e-12
CR2,Complement receptor type 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,42217,0.0299050756842137,0.00501236596597226,0.020080838390908,0.0397293129775193,2.48778384522012e-09
CR2,Complement receptor type 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42217,0.0268507955138165,0.00497790717138644,0.0170940974578991,0.0366074935697339,7.0060483484754e-08
CR2,Complement receptor type 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42217,0.0320370206341284,0.00505579036128651,0.0221276715260068,0.0419463697422499,2.42131226598749e-10
CR2,Complement receptor type 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,42217,0.0250215728709399,0.00490950317412689,0.0153989466496512,0.0346441990922286,3.50517223394691e-07
CR2,Complement receptor type 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42217,0.00601281418263473,0.00470711023376498,-0.00321312187554462,0.0152387502408141,0.201486473906047
CR2,Complement receptor type 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42217,0.0103285020889584,0.00472030849753495,0.0010766974337899,0.0195803067441269,0.0286793289662544
CR2,Complement receptor type 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42217,0.00469129946814958,0.0046948737438013,-0.00451065306970096,0.0138932520060001,0.317696835664984
CR2,Complement receptor type 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42217,-0.0112852510501591,0.00461129664890188,-0.0203233924820068,-0.00224710961831144,0.0144054274692814
CR2,Complement receptor type 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42217,-0.019051292522795,0.00459681880903278,-0.0280610573884993,-0.0100415276570908,3.4268824004505e-05
CR2,Complement receptor type 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42217,-0.000481886564902359,0.00467111449504394,-0.00963727097518849,0.00867349784538377,0.917835059469005
CR2,Complement receptor type 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42217,0.0221559783653989,0.00484717897058326,0.0126555075830557,0.0316564491477421,4.89902737356497e-06
CR2,Complement receptor type 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42217,0.025334242931879,0.00485671219013656,0.0158150870392113,0.0348533988245466,1.85173370219467e-07
CR2,Complement receptor type 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,42217,0.0209784056242226,0.00486127031671644,0.0114503158034584,0.0305064954449868,1.60426500837891e-05
CR2,Complement receptor type 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,42217,0.00791767876603199,0.00476770076637628,-0.00142701473606551,0.0172623722681295,0.0967985021171053
CR2,Complement receptor type 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,42217,0.00833305707161689,0.00480882464518267,-0.00109223923294115,0.0177583533761749,0.0831418201075337
CR2,Complement receptor type 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42217,0.0144946042594974,0.00489328236952781,0.0049037708152229,0.0240854377037719,0.00306033107920963
CR2,Complement receptor type 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42217,-0.00215265376405161,0.00467788778205926,-0.0113213138168878,0.00701600628878454,0.64539692541767
CR2,Complement receptor type 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,42217,0.0327417808087323,0.00489984795014599,0.0231380788264462,0.0423454827910184,2.44528116563295e-11
CR2,Complement receptor type 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42217,0.00693316484074262,0.00464692441316035,-0.00217480700905166,0.0160411366905369,0.135724928006553
CR2,Complement receptor type 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42217,0.00762656660037507,0.00467997081914992,-0.00154617620515878,0.0167993094059089,0.103205301326689
CR2,Complement receptor type 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42217,0.0135225667462983,0.00466393480513999,0.00438125452822392,0.0226638789643727,0.00374486706366216
CR2,Complement receptor type 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42217,-0.00854903344613207,0.00470577784663056,-0.017772358025528,0.000674291133263828,0.0692835116305658
CR2,Complement receptor type 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42217,-0.0137417417793178,0.00473693791693854,-0.0230261400965174,-0.00445734346211828,0.00372598296489442
CR2,Complement receptor type 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42217,0.00337840555021272,0.00466942197658954,-0.00577366152390277,0.0125304726243282,0.469374824605925
CR2,Complement receptor type 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42217,0.0311240874326322,0.00475730244453605,0.0217997746413416,0.0404484002239229,6.27109515723778e-11
CR2,Complement receptor type 2,NMR metabolomics,X23523.Concentration of IDL Particles,42217,-0.0204825454194132,0.00459913740959407,-0.0294968547422176,-0.0114682360966088,8.51295811708443e-06
CR2,Complement receptor type 2,NMR metabolomics,X23524.Total Lipids in IDL,42217,-0.034002632720135,0.00469444959758928,-0.04320375393141,-0.02480151150886,4.61901743045201e-13
CR2,Complement receptor type 2,NMR metabolomics,X23525.Phospholipids in IDL,42217,-0.0274472447130221,0.00469610121870526,-0.0366516031016844,-0.0182428863243597,5.19133894225358e-09
CR2,Complement receptor type 2,NMR metabolomics,X23526.Cholesterol in IDL,42217,-0.0404877286192748,0.00471416991557791,-0.0497275016538075,-0.0312479555847421,9.75806073898396e-18
CR2,Complement receptor type 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42217,-0.0412103236712524,0.00471945773811597,-0.0504604608379597,-0.0319601865045451,2.79045199603556e-18
CR2,Complement receptor type 2,NMR metabolomics,X23528.Free Cholesterol in IDL,42217,-0.0372254600636354,0.00468442258249151,-0.0464069283253188,-0.0280439918019521,2.06608568288096e-15
CR2,Complement receptor type 2,NMR metabolomics,X23529.Triglycerides in IDL,42217,0.0198095765698351,0.00459862854178489,0.0107962646279367,0.0288228885117335,1.66106574257914e-05
CR2,Complement receptor type 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,42217,-0.0130041345151062,0.00456413655131136,-0.0219498421556764,-0.00405842687453589,0.00438951539460956
CR2,Complement receptor type 2,NMR metabolomics,X23531.Total Lipids in Large LDL,42217,-0.0325980701989564,0.00457524419633717,-0.0415655488237773,-0.0236305915741356,1.09406463761581e-12
CR2,Complement receptor type 2,NMR metabolomics,X23532.Phospholipids in Large LDL,42217,-0.0341947387947916,0.00458866538893648,-0.0431885229571072,-0.0252009546324761,9.74720271965976e-14
CR2,Complement receptor type 2,NMR metabolomics,X23533.Cholesterol in Large LDL,42217,-0.0347097378480693,0.00457646006484656,-0.0436795995751685,-0.02573987612097,3.55612535878804e-14
CR2,Complement receptor type 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42217,-0.0324414989827771,0.00457095260516334,-0.0414005660888973,-0.023482431876657,1.33496809543667e-12
CR2,Complement receptor type 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42217,-0.0402478434273007,0.00461163817553752,-0.0492866542513542,-0.0312090326032472,2.90443705347922e-18
CR2,Complement receptor type 2,NMR metabolomics,X23536.Triglycerides in Large LDL,42217,0.0113989937599599,0.00454754106943507,0.00248581326386714,0.0203121742560526,0.0122004505754485
CR2,Complement receptor type 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42217,-0.00966533674437918,0.00461519977773449,-0.0187111283087388,-0.000619545180019585,0.036257030103108
CR2,Complement receptor type 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,42217,-0.0199560677534581,0.00458217575029093,-0.0289371322240283,-0.0109750032828878,1.33947022861024e-05
CR2,Complement receptor type 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,42217,-0.0216833764977719,0.00459863585572518,-0.0306967027749933,-0.0126700502205505,2.43896955460763e-06
CR2,Complement receptor type 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,42217,-0.0220256779806082,0.00457563290570955,-0.0309939184757989,-0.0130574374854175,1.49760020638189e-06
CR2,Complement receptor type 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42217,-0.017095476908633,0.00459437113209119,-0.0261004443275317,-0.00809050948973425,0.000199264102123729
CR2,Complement receptor type 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42217,-0.0336698047618044,0.00454808757828632,-0.0425840564152456,-0.0247555531083632,1.40876921024872e-13
CR2,Complement receptor type 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,42217,0.0167483416523764,0.00457815183151367,0.00777516406260962,0.0257215192421432,0.000254832473248585
CR2,Complement receptor type 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,42217,-0.00159628197275496,0.00461856906982322,-0.0106486773496085,0.00745611340409856,0.729631678297064
CR2,Complement receptor type 2,NMR metabolomics,X23545.Total Lipids in Small LDL,42217,-0.0148180149260135,0.00455127008209723,-0.0237385042869241,-0.00589752556510293,0.0011335059283405
CR2,Complement receptor type 2,NMR metabolomics,X23546.Phospholipids in Small LDL,42217,-0.0164261622211963,0.00453588098803121,-0.0253164889577375,-0.00753583548465513,0.000294096716898752
CR2,Complement receptor type 2,NMR metabolomics,X23547.Cholesterol in Small LDL,42217,-0.0183983491091954,0.00456392450999933,-0.0273436411487941,-0.00945305706959669,5.57815365813025e-05
CR2,Complement receptor type 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42217,-0.0127420087010526,0.00456692528130302,-0.0216931822524065,-0.00379083514969867,0.00527710712746948
CR2,Complement receptor type 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42217,-0.0304972972571151,0.00455693473115898,-0.0394288893301867,-0.0215657051840435,2.27968895436281e-11
CR2,Complement receptor type 2,NMR metabolomics,X23550.Triglycerides in Small LDL,42217,0.0265923582076165,0.00463424751169275,0.0175092330846987,0.0356754833305342,9.77104084161821e-09
CR2,Complement receptor type 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42217,-0.0256942451540936,0.00529394166142291,-0.0360703708104825,-0.0153181194977047,1.22634699810573e-06
CR2,Complement receptor type 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42217,-0.0241725756804789,0.00531160505194298,-0.0345833215822871,-0.0137618297786706,5.38794111854541e-06
CR2,Complement receptor type 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42217,-0.0194777603464096,0.00528744851936607,-0.0298411594443671,-0.00911436124845211,0.000230696864053041
CR2,Complement receptor type 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42217,-0.0348746209990728,0.00536799685677516,-0.0453958948383521,-0.0243533471597935,8.49175896335263e-11
CR2,Complement receptor type 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42217,-0.0417060378154858,0.00539062319615416,-0.052271659279948,-0.0311404163510237,1.09120009140828e-14
CR2,Complement receptor type 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42217,-0.0113396185976496,0.00523156399180044,-0.0215934840215785,-0.00108575317372072,0.0302110563493541
CR2,Complement receptor type 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42217,0.0239395579940217,0.00442821399184838,0.0152602585699989,0.0326188574180446,6.54819915229103e-08
CR2,Complement receptor type 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,42217,-0.0617458765493567,0.00531937831058792,-0.072171858038109,-0.0513198950606044,5.26872360223363e-31
CR2,Complement receptor type 2,NMR metabolomics,X23559.Total Lipids in Large HDL,42217,-0.0600521319126534,0.00527570661136612,-0.070392516870931,-0.0497117469543758,6.95456631398092e-30
CR2,Complement receptor type 2,NMR metabolomics,X23560.Phospholipids in Large HDL,42217,-0.0584017928589574,0.00522666155431082,-0.0686460495054066,-0.0481575362125082,7.31253408170367e-29
CR2,Complement receptor type 2,NMR metabolomics,X23561.Cholesterol in Large HDL,42217,-0.0654475760998568,0.00534930302099856,-0.075932210021014,-0.0549629421786996,3.06514631411983e-34
CR2,Complement receptor type 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42217,-0.0679743292419676,0.00536515355278365,-0.0784900302054236,-0.0574586282785117,1.4018696307193e-36
CR2,Complement receptor type 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42217,-0.0553193909246937,0.00529659757767695,-0.0657007221769405,-0.0449380596724469,1.94083197807583e-25
CR2,Complement receptor type 2,NMR metabolomics,X23564.Triglycerides in Large HDL,42217,0.0133394437407423,0.00466200661643602,0.00420191077252766,0.0224769767089569,0.00422537529347892
CR2,Complement receptor type 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42217,-0.0690997214756844,0.00486587621491913,-0.0786368388569259,-0.0595626040944429,1.90893043526949e-45
CR2,Complement receptor type 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,42217,-0.0644141760324555,0.00478921095473842,-0.0738010295037428,-0.0550273225611682,5.63295441218463e-41
CR2,Complement receptor type 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,42217,-0.0573072161039697,0.00471452864029743,-0.0665476922389526,-0.0480667399689867,8.03256594741057e-34
CR2,Complement receptor type 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,42217,-0.0781447814224942,0.00491158669051425,-0.0877714913359021,-0.0685180715090863,1.7343732647572e-56
CR2,Complement receptor type 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42217,-0.0791427145610942,0.00490357631121481,-0.0887537241310753,-0.0695317049911132,4.62819941121478e-58
CR2,Complement receptor type 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42217,-0.0713256119345485,0.00494175285847957,-0.0810114475371685,-0.0616397763319286,7.08647126273841e-47
CR2,Complement receptor type 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,42217,0.0188501963859709,0.0047820280073399,0.00947742149158469,0.0282229712803571,8.12485387905883e-05
CR2,Complement receptor type 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,42217,-0.0571369315154699,0.00456335259551956,-0.0660811026026882,-0.0481927604282515,9.03932984059163e-36
CR2,Complement receptor type 2,NMR metabolomics,X23573.Total Lipids in Small HDL,42217,-0.0479923633207113,0.00456699587863877,-0.0569436752428433,-0.0390410513985793,9.90056725976452e-26
CR2,Complement receptor type 2,NMR metabolomics,X23574.Phospholipids in Small HDL,42217,-0.0458603530035487,0.00454459910698339,-0.0547677672532361,-0.0369529387538612,7.33180217689722e-24
CR2,Complement receptor type 2,NMR metabolomics,X23575.Cholesterol in Small HDL,42217,-0.0616019409189441,0.00453580141821864,-0.0704921116986526,-0.0527117701392355,9.67024670115726e-42
CR2,Complement receptor type 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42217,-0.0638705055565776,0.00456111955072903,-0.0728102998760065,-0.0549307112371487,3.01763398178033e-44
CR2,Complement receptor type 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42217,-0.0485069726370499,0.00453122175425848,-0.0573881672753965,-0.0396257779987033,1.2299966197056e-26
CR2,Complement receptor type 2,NMR metabolomics,X23578.Triglycerides in Small HDL,42217,0.0347119684123389,0.00513938753733498,0.0246387688391624,0.0447851679855155,1.49550583575594e-11
CR2,Complement receptor type 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41836,0.0120276447804095,0.00515857666661726,0.0019168345138397,0.0221384550469793,0.019737616368314
CR2,Complement receptor type 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41836,-0.0141187404431776,0.00495334780858023,-0.0238273021479948,-0.0044101787383603,0.0043739581927758
CR2,Complement receptor type 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41836,-0.0102179800804796,0.00501528377983088,-0.0200479362889482,-0.000388023872011112,0.0416329994014918
CR2,Complement receptor type 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41836,-0.0180184141542383,0.00495538444432081,-0.0277309676651071,-0.00830586064336948,0.000277816555427788
CR2,Complement receptor type 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41836,0.00817626163039677,0.00501617973073689,-0.00165545064184754,0.0180079739026411,0.103129982688372
CR2,Complement receptor type 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42142,0.0278011228885411,0.00505375184999311,0.0178957692625546,0.0377064765145276,3.84308473291306e-08
CR2,Complement receptor type 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42142,-0.020585325214915,0.00511530647391264,-0.0306113259037838,-0.0105593245260462,5.74654586239693e-05
CR2,Complement receptor type 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42142,-0.0249570678505676,0.00508183885046515,-0.0349174719974793,-0.0149966637036559,9.16560153852881e-07
CR2,Complement receptor type 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42142,0.00425275831309709,0.00512762354624632,-0.00579738383754571,0.0143029004637399,0.406902942149656
CR2,Complement receptor type 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42142,0.0100269735970569,0.00510036309882296,3.0261923363941e-05,0.02002368527075,0.0493267158722905
CR2,Complement receptor type 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42217,0.0543071026578631,0.005262914820639,0.0439917896094106,0.0646224157063155,7.15312878052558e-25
CR2,Complement receptor type 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42217,-0.000962615523830815,0.00494538222588961,-0.0106555646865744,0.00873033363891281,0.845670356072903
CR2,Complement receptor type 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42217,-0.00825694105874788,0.00502394974665623,-0.0181038825621941,0.00159000044469833,0.10029933443567
CR2,Complement receptor type 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42217,0.017619703534109,0.00501354598667209,0.00779315340023171,0.0274462536679863,0.000442147188627096
CR2,Complement receptor type 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42217,-0.019418902309251,0.00503767076775206,-0.029292737014045,-0.00954506760445695,0.000116385814139609
CR2,Complement receptor type 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42217,-0.0202679157150816,0.00485064836050242,-0.0297751865016663,-0.0107606449284968,2.95407533993044e-05
CR2,Complement receptor type 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42217,-0.0331791232741583,0.00501197765115514,-0.0430025994704224,-0.0233556470778942,3.72739408766544e-11
CR2,Complement receptor type 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42217,-0.0350478792230314,0.00504391461693667,-0.0449339518722272,-0.0251618065738355,3.85842732933928e-12
CR2,Complement receptor type 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42217,-0.0268686516056364,0.00490587154646886,-0.0364841598367153,-0.0172531433745574,4.40678872566805e-08
CR2,Complement receptor type 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42217,0.0303893095439053,0.00497272324829034,0.0206427719772562,0.0401358471105543,1.01581955508667e-09
CR2,Complement receptor type 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42217,-0.0428979142407477,0.00488068071858338,-0.0524640484491711,-0.0333317800323242,1.68279494276546e-18
CR2,Complement receptor type 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42217,-0.0243487821308483,0.00472071846134474,-0.0336013903150839,-0.0150961739466126,2.53300902612415e-07
CR2,Complement receptor type 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42217,-0.0100139363626656,0.00465378096565286,-0.0191353470553452,-0.000892525669986009,0.0314318143405879
CR2,Complement receptor type 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42217,-0.0429234322643221,0.00492131342361887,-0.052569206574615,-0.0332776579540291,3.04836221593355e-18
CR2,Complement receptor type 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42217,0.0300637108358173,0.00476637560042137,0.0207216146589914,0.0394058070126432,2.92425615985818e-10
CR2,Complement receptor type 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42217,0.0489103358024356,0.00461342086028059,0.0398680309162856,0.0579526406885855,3.69840371850504e-26
CR2,Complement receptor type 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42217,-0.041860400390217,0.00486507478778824,-0.0513959469742819,-0.032324853806152,8.51355431754104e-18
CR2,Complement receptor type 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42217,-0.0441419691566131,0.0049303381435793,-0.0538054319180285,-0.0344785063951976,3.89755440421934e-19
CR2,Complement receptor type 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42217,-0.0195702038373979,0.004307695028381,-0.0280132860930247,-0.0111271215817712,5.59145883285433e-06
CR2,Complement receptor type 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42217,0.034906576159028,0.0048078523387655,0.0254831855750477,0.0443299667430084,4.07094157762933e-13
CR2,Complement receptor type 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42217,0.0503420623847094,0.00450119785237958,0.0415197145940455,0.0591644101753734,6.51639117556552e-29
CR2,Complement receptor type 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42217,-0.058297821997143,0.00471634050083022,-0.0675418493787702,-0.0490537946155157,6.55214700855354e-35
CR2,Complement receptor type 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42217,-0.0571002730559414,0.00464907619576488,-0.0662124623996405,-0.0479880837122422,1.72123427897814e-34
CR2,Complement receptor type 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42217,-0.0262101948410085,0.00434902251642778,-0.0347342789732069,-0.01768611070881,1.71676654772079e-09
CR2,Complement receptor type 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42217,0.0496140027324547,0.00475814817185183,0.0402880323156251,0.0589399731492843,2.32186289614443e-25
CR2,Complement receptor type 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42217,-0.00363257060991657,0.0046391674652628,-0.0127253388418317,0.00546019762199851,0.433627756971648
CR2,Complement receptor type 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42217,-0.0458836251151304,0.00470975434126528,-0.0551147436240103,-0.0366525066062504,2.35526209250466e-22
CR2,Complement receptor type 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42217,-0.0187952310706934,0.00451763108614461,-0.0276497879995369,-0.00994067414185002,3.19616105027549e-05
CR2,Complement receptor type 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42217,-0.0508320309994354,0.00503974614598601,-0.060709933445568,-0.0409541285533028,7.70793879299106e-24
CR2,Complement receptor type 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42217,0.043566813193149,0.00463654811676979,0.0344791788842802,0.0526544475020178,6.53255244508295e-21
CR2,Complement receptor type 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42217,-0.00922091626133282,0.00476967367776827,-0.0185694766697586,0.000127644147092978,0.0532275421698329
CR2,Complement receptor type 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42217,-0.03693055342189,0.00469919513692913,-0.0461409758902711,-0.0277201309535089,4.16446342220576e-15
CR2,Complement receptor type 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42217,0.0125686578052192,0.00476067402420881,0.00323773671776996,0.0218995788926685,0.00829759516680499
CR2,Complement receptor type 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42217,-0.0462252544077338,0.00487475697120496,-0.0557797780712955,-0.0366707307441721,2.88537386096165e-21
CR2,Complement receptor type 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42217,0.0404339687168133,0.00462637539228962,0.0313662729479256,0.0495016644857009,2.60361925984998e-18
CR2,Complement receptor type 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42217,-0.00372361250760161,0.00473503735718466,-0.0130042857276835,0.00555706071248032,0.431649449582916
CR2,Complement receptor type 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42217,-0.0377429883393665,0.00460941705218214,-0.0467774457616435,-0.0287085309170895,2.88517005218674e-16
CR2,Complement receptor type 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42217,0.00516887322615425,0.00469284809678769,-0.00402910904354961,0.0143668554958581,0.270726284017101
CR2,Complement receptor type 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42217,-0.040199266083697,0.00463907896665293,-0.0492918608583367,-0.0311066713090573,5.00374760295452e-18
CR2,Complement receptor type 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42217,0.0435065935257843,0.00472146744069461,0.0342525173420228,0.0527606697095457,3.57454660365972e-20
CR2,Complement receptor type 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42204,-0.00383288841442638,0.00504702696572779,-0.0137250612672528,0.00605928443840009,0.447605602458875
CR2,Complement receptor type 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42204,-0.0211634515678622,0.00438304182585067,-0.0297542135465295,-0.0125726895891949,1.39072372423662e-06
CR2,Complement receptor type 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42204,-0.049415056865494,0.00406249435422272,-0.0573775457997705,-0.0414525679312175,7.26960963149155e-34
CR2,Complement receptor type 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42204,0.0384768680689201,0.0052168461314149,0.0282518496513468,0.0487018864864933,1.73192213260796e-13
CR2,Complement receptor type 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42204,0.0394030444869766,0.00491456227516131,0.0297705024276604,0.0490355865462928,1.16573778688262e-15
CR2,Complement receptor type 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42217,0.0187089037849319,0.00464926133441982,0.00959635156946904,0.0278214560003947,5.75127750945257e-05
CR2,Complement receptor type 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42217,-0.0452544693601681,0.00489528993268317,-0.0548492376282271,-0.0356597010921091,2.70967594149555e-20
CR2,Complement receptor type 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42217,-0.0442811004208256,0.0047105598822935,-0.0535137977901208,-0.0350484030515303,6.29043075315845e-21
CR2,Complement receptor type 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42217,-0.0167530146131415,0.00470155537009407,-0.0259680631385258,-0.00753796608775707,0.000367484979449852
CR2,Complement receptor type 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42217,0.0588349546543428,0.00469380548431991,0.0496350959050758,0.0680348134036098,7.61362562929374e-36
CR2,Complement receptor type 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42217,0.0694572783979,0.00500082949572315,0.0596556525862827,0.0792589042095174,1.46042773712348e-43
CR2,Complement receptor type 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42217,-0.0711918219812734,0.00498864967987966,-0.0809695753538375,-0.0614140686087093,7.12864317478479e-46
CR2,Complement receptor type 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42217,-0.0585106075478736,0.00475228067070157,-0.0678250776624487,-0.0491961374332986,1.19157962393909e-34
CR2,Complement receptor type 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42217,-0.0720546001699932,0.00519972981170118,-0.0822460706009275,-0.0618631297390589,2.2607105038003e-43
CR2,Complement receptor type 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42217,0.0660898696409062,0.00492011414684259,0.0564464459130947,0.0757332933687177,7.09139739357266e-41
CR2,Complement receptor type 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42217,0.00373548067190499,0.00461291958766232,-0.00530584171991316,0.0127768030637231,0.418076960317032
CR2,Complement receptor type 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42217,-0.0406569921601281,0.00455497242623907,-0.0495847381155567,-0.0317292462046996,4.9818136935427e-19
CR2,Complement receptor type 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42217,-0.0383844684404786,0.00449241020061991,-0.0471895924336937,-0.0295793444472636,1.42949739091916e-17
CR2,Complement receptor type 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42217,-0.0111402920071634,0.00487903716990961,-0.0207032048601862,-0.00157737915414053,0.0224282005436828
CR2,Complement receptor type 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42217,0.0698619250759603,0.00511964274333008,0.0598274252990334,0.0798964248528873,4.04276625172427e-42
CR2,Complement receptor type 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52074,0.00442031692523473,0.00390277014979555,-0.00322911256836455,0.012069746418834,0.257389590066866
CR2,Complement receptor type 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52074,0.00494630183785242,0.00379066955030713,-0.00248341048074956,0.0123760141564544,0.191952527408115
CR2,Complement receptor type 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50517,0.00487452374322541,0.00361398009600587,-0.00220887724494611,0.0119579247313969,0.177416271486934
CR2,Complement receptor type 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50517,0.00470839955201911,0.00393433146936102,-0.0030028901279285,0.0124196892319667,0.231418109840463
CR2,Complement receptor type 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50517,0.00346339648476222,0.00390041632925744,-0.00418141952058236,0.0111082124901068,0.374574384479144
CR2,Complement receptor type 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50517,-5.28822859149804e-05,0.00358687388849182,-0.00708315510735895,0.00697739053552898,0.988237124885319
CR2,Complement receptor type 2,Working and living environment,X24009.Traffic intensity on the nearest road,52074,-0.109909684223625,0.0506884402812296,-0.209259027174835,-0.0105603412724154,0.0301429712416307
CR2,Complement receptor type 2,Working and living environment,X24010.Inverse distance to the nearest road,52074,0.00556852616239483,0.00340687466195236,-0.0011089481750318,0.0122460004998215,0.102167960340267
CR2,Complement receptor type 2,Working and living environment,X24011.Traffic intensity on the nearest major road,52074,0.00359544431070501,0.00339819971316198,-0.00306502712709248,0.0102559157485025,0.290046338596921
CR2,Complement receptor type 2,Working and living environment,X24012.Inverse distance to the nearest major road,52074,-0.000940571702170184,0.00345195923840368,-0.0077064118094414,0.00582526840510103,0.785259406554059
CR2,Complement receptor type 2,Working and living environment,X24013.Total traffic load on major roads,52074,-0.0409834745997118,0.0353201078688238,-0.110210886022607,0.028243936823183,0.24592058562417
CR2,Complement receptor type 2,Working and living environment,X24015.Sum of road length of major roads within 100m,52074,-0.0462490975396948,0.0343771700442501,-0.113628350826425,0.0211301557470353,0.178527372466503
CR2,Complement receptor type 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52074,0.00470315751957436,0.00391910447646485,-0.00297828725429674,0.0123846022934455,0.230128447153453
CR2,Complement receptor type 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52074,0.00505670452663023,0.00391916565914694,-0.00262486016529778,0.0127382692185582,0.196976488653359
CR2,Complement receptor type 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52074,0.00609922346364336,0.00387402401023583,-0.00149386359641887,0.0136923105237056,0.115410862178012
CR2,Complement receptor type 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52037,0.00364823044922194,0.00378758128043533,-0.00377542886043131,0.0110718897588752,0.33545284261929
CR2,Complement receptor type 2,Working and living environment,X24020.Average daytime sound level of noise pollution,52074,-0.000521875806373304,0.00340833983641988,-0.00720222188575627,0.00615847027300967,0.878307086380346
CR2,Complement receptor type 2,Working and living environment,X24021.Average evening sound level of noise pollution,52074,-0.000546190985054408,0.00340869038698384,-0.00722722414354274,0.00613484217343392,0.872697458266984
CR2,Complement receptor type 2,Working and living environment,X24022.Average night-time sound level of noise pollution,52074,-0.000516725722506708,0.00340845272309004,-0.00719729305976319,0.00616384161474978,0.879502743488005
CR2,Complement receptor type 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52074,-0.000549383823802002,0.00340853111367186,-0.00723010480659885,0.00613133715899485,0.871953764184038
CR2,Complement receptor type 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52074,-0.000544049853270145,0.00340860916336655,-0.00722492381346859,0.0061368241069283,0.8731892711235
CR2,Complement receptor type 2,Health and medical history,X2405.Number of children fathered,52064,-0.0560906584981447,0.0266880484426468,-0.108399233445733,-0.00378208355055693,0.0355889257571528
CR2,Complement receptor type 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49542,-0.000820520074318799,0.00402850958490497,-0.00871639886073254,0.00707535871209494,0.838606862266917
CR2,Complement receptor type 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49542,0.00356036682387467,0.00362237875027037,-0.00353949552665525,0.0106602291744046,0.32567742246482
CR2,Complement receptor type 2,Working and living environment,"X24502.Water percentage, buffer 1000m",49542,-0.00324801452482871,0.00365930910463411,-0.0104202603699116,0.00392423132025413,0.374764417433825
CR2,Complement receptor type 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49542,-0.00159223855636752,0.00378936531284785,-0.00901939456954931,0.00583491745681426,0.674353833842989
CR2,Complement receptor type 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49542,0.00351018919767233,0.00365861192072055,-0.00366069016693995,0.0106810685622846,0.337352258599642
CR2,Complement receptor type 2,Working and living environment,"X24505.Water percentage, buffer 300m",49542,-0.00126396501924356,0.00367972085324226,-0.00847621789159838,0.00594828785311126,0.731229692041737
CR2,Complement receptor type 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52149,-0.00160028917555735,0.00387018255488468,-0.00918584698313131,0.00598526863201662,0.679250013867326
CR2,Complement receptor type 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52149,-0.0054874164130472,0.00362049055662543,-0.012583577904033,0.00160874507793865,0.129619908277361
CR2,Complement receptor type 2,Working and living environment,X24508.Distance (Euclidean) to coast,52149,0.00238721160591899,0.00341829148317212,-0.00431263970109836,0.00908706291293635,0.484956499791981
CR2,Complement receptor type 2,Lifestyle factors,X2867.Age started smoking in former smokers,35534,-0.00363340248913251,0.00636594634950996,-0.016110657334172,0.00884385235590701,0.568183503901045
CR2,Complement receptor type 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37065,0.0679899721068015,0.054356497795996,-0.0385487635733508,0.174528707786954,0.211036228620542
CR2,Complement receptor type 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37064,0.0885191491347229,0.0619440304513706,-0.0328911505499635,0.209929448819409,0.153035904336266
CR2,Complement receptor type 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37065,0.0577500913080624,0.0582241308535094,-0.056369205164816,0.171869387780941,0.321294978060376
CR2,Complement receptor type 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37053,0.118907201698099,0.0584117211502976,0.00442022824351591,0.233394175152683,0.0418142649199928
CR2,Complement receptor type 2,Mental health,X28739.Difficulty with standing for long periods,37070,0.0147358372472446,0.0488215142957483,-0.0809543307724221,0.110426005266911,0.762788454863583
CR2,Complement receptor type 2,Mental health,X28740.Difficulty with taking care of household responsibilities,37087,0.108539609368173,0.0571380420969575,-0.00345095314186335,0.22053017187821,0.0575190876919665
CR2,Complement receptor type 2,Mental health,X28741.Difficulty learning a new task,37041,0.148842012439119,0.0674006599256101,0.0167367189849233,0.280947305893315,0.0272489818043975
CR2,Complement receptor type 2,Mental health,X28742.Difficulty with joining in community activities,36615,0.105187778174504,0.0625530989039967,-0.0174162956773291,0.227791852026338,0.0926900968733096
CR2,Complement receptor type 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,37033,0.134738610764453,0.0546731142967264,0.0275793067428691,0.241897914786037,0.0137425537851098
CR2,Complement receptor type 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37093,0.0753152115253,0.0733646663894865,-0.0684795345980935,0.219109957648694,0.304644233154449
CR2,Complement receptor type 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34920,0.124270277798169,0.0489418128500342,0.0283443246121019,0.220196230984236,0.0111362023078707
CR2,Complement receptor type 2,Lifestyle factors,X2897.Age stopped smoking,35526,0.0177378388605506,0.00668940588643482,0.0046266033231384,0.0308490743979629,0.00802863663501573
CR2,Complement receptor type 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36127,0.0145723010458007,0.0131860735496705,-0.0112724031115535,0.0404170052031548,0.269139388464658
CR2,Complement receptor type 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36127,-0.0111057814397056,0.0149171328065486,-0.0403433617405409,0.0181317988611297,0.456598253859827
CR2,Complement receptor type 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36127,-0.0174719960540534,0.0504197924752591,-0.116294789305561,0.0813507971974544,0.728953750888956
CR2,Complement receptor type 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36127,0.00296013517869358,0.0487988115099169,-0.0926855353807436,0.0986058057381308,0.951631610692701
CR2,Complement receptor type 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36127,-0.0174568683529625,0.0606894448813594,-0.136408180320427,0.101494443614502,0.773628268286765
CR2,Complement receptor type 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36127,-0.0451066413604437,0.0543135712494547,-0.151561241009375,0.0613479582884874,0.406290599868235
CR2,Complement receptor type 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36127,-0.00439107585734573,0.0224243755094422,-0.0483428518558524,0.0395607001411609,0.844758622500334
CR2,Complement receptor type 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36127,0.0456230738741717,0.0422770071627448,-0.0372398601648081,0.128486007913151,0.280557113873774
CR2,Complement receptor type 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,36081,0.0655091189817511,0.0587627585142793,-0.0496658877062362,0.180684125669738,0.264969070818713
CR2,Complement receptor type 2,Mental health,X29003.Recent feelings of depression,36081,0.100396037102962,0.0582882094461665,-0.0138488534115241,0.214640927617448,0.0850371053437658
CR2,Complement receptor type 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36086,0.107658997510695,0.045838504573959,0.0178155285457359,0.197502466475655,0.0188670457426497
CR2,Complement receptor type 2,Mental health,X29005.Recent feelings of tiredness or low energy,36087,0.147031286043794,0.0448382841970944,0.0591482490174891,0.234914323070099,0.00104597301084847
CR2,Complement receptor type 2,Mental health,X29006.Recent poor appetite or overeating,36093,0.11884348144018,0.0716434398853137,-0.021577660735035,0.259264623615395,0.0971941847807345
CR2,Complement receptor type 2,Mental health,X29007.Recent feelings of inadequacy,36070,0.0653995962964861,0.063916043398251,-0.0598758487640858,0.190675041357058,0.306241253675109
CR2,Complement receptor type 2,Mental health,X29008.Recent trouble concentrating on things,36088,0.149350354693687,0.0609131533583149,0.0299605741113896,0.268740135275984,0.0142347855197634
CR2,Complement receptor type 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36086,0.298179690680184,0.104519568417839,0.0933213365812199,0.503038044779148,0.00434465321548378
CR2,Complement receptor type 2,Mental health,X29010.Recent thoughts of suicide or self-harm,36064,0.124919989189946,0.114457359513667,-0.099416435456841,0.349256413836733,0.275127435605052
CR2,Complement receptor type 2,Mental health,X29038#0.Substances taken for depression_None of options listed,36026,0.0184496562250188,0.0261985687598163,-0.0328995385442212,0.0697988509942589,0.481315480288182
CR2,Complement receptor type 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36026,0.038149705587674,0.0481690825834578,-0.0562616962759034,0.132561107451251,0.428388489786364
CR2,Complement receptor type 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36026,-0.0261293825676688,0.0288690735929115,-0.0827127668097753,0.0304540016744378,0.365442067714985
CR2,Complement receptor type 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36026,0.0775071285606321,0.0867068202236,-0.0924382390776239,0.247452496198888,0.371404971692958
CR2,Complement receptor type 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36026,0.0458069780273897,0.0571333845761924,-0.0661744557419474,0.157788411796727,0.422720335023147
CR2,Complement receptor type 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36026,-0.0305025597885297,0.0655644288047451,-0.15900884024583,0.0980037206687708,0.641780174408256
CR2,Complement receptor type 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36026,0.0564882350079001,0.067664182650302,-0.0761335629866919,0.189110033002492,0.403839077834312
CR2,Complement receptor type 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36026,0.0480044227770128,0.0795197259504841,-0.107854240085936,0.203863085639962,0.54607523209191
CR2,Complement receptor type 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36026,-0.0991431921214457,0.0570055037629781,-0.210873979496883,0.0125875952539914,0.0820434329207738
CR2,Complement receptor type 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36026,-0.00160537523226386,0.0246037746823796,-0.0498287736097278,0.0466180231452001,0.947977389728319
CR2,Complement receptor type 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36026,0.00331073288685096,0.0401065696083044,-0.0752981435454256,0.0819196093191276,0.934212862053573
CR2,Complement receptor type 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36026,0.0322270609996737,0.0627530333107527,-0.0907688842894016,0.155223006288749,0.607579240720474
CR2,Complement receptor type 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36026,0.0411965456420927,0.0770116907232285,-0.109746368175435,0.192139459459621,0.592708156192363
CR2,Complement receptor type 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36026,-0.00411371722822222,0.0461650155737525,-0.0945971477527772,0.0863697132963328,0.928997707566849
CR2,Complement receptor type 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36026,-0.032444556261069,0.0712192058709469,-0.172034199768125,0.107145087245987,0.648720390348205
CR2,Complement receptor type 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36026,-0.0310085681867067,0.0700746200385151,-0.168354823462196,0.106337687088783,0.658134651983151
CR2,Complement receptor type 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36026,0.0290058948461015,0.039862645815331,-0.0491248909519472,0.10713668064415,0.466853253517885
CR2,Complement receptor type 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36026,0.0135776085453692,0.0377759256282649,-0.0604632056860301,0.0876184227767685,0.719287464716494
CR2,Complement receptor type 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36026,-0.0392884644455564,0.0561466987874209,-0.149335994068901,0.0707590651777885,0.484107455460403
CR2,Complement receptor type 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35968,0.126143572437849,0.0567805753408113,0.0148536447698589,0.237433500105839,0.0263408097457914
CR2,Complement receptor type 2,Mental health,X29059.Recent inability to stop or control worrying,35974,0.120295389167364,0.060129861694955,0.00244086024525264,0.238149918089476,0.0454728589355019
CR2,Complement receptor type 2,Mental health,X29060.Recent worrying too much about different things,35972,0.136500117046823,0.0535948471302036,0.0314542166716245,0.241546017422023,0.0108889572221721
CR2,Complement receptor type 2,Mental health,X29061.Recent trouble relaxing,35969,0.142379579036488,0.0570443843133336,0.0305725857823538,0.254186572290622,0.0125839421916438
CR2,Complement receptor type 2,Mental health,X29062.Recent restlessness,35977,0.107815005441127,0.0784346916838724,-0.0459169902592625,0.261547001141517,0.16930247964364
CR2,Complement receptor type 2,Mental health,X29063.Recent easy annoyance or irritability,35965,0.0737022755690604,0.0548506131457978,-0.0338049261967033,0.181209477334824,0.179089732556023
CR2,Complement receptor type 2,Mental health,X29064.Recent feelings of foreboding,35968,0.142222793650243,0.0682338228728488,0.00848450081945926,0.275961086481027,0.0371632112882001
CR2,Complement receptor type 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36026,0.0449556051509715,0.0312423483577332,-0.0162793976301857,0.106190607932129,0.150212023497263
CR2,Complement receptor type 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36026,0.0250560147612828,0.0475357102546166,-0.0681139773377657,0.118226006860331,0.598140740984284
CR2,Complement receptor type 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36026,-0.0409135060408185,0.0646468296190653,-0.167621292094186,0.0857942800125494,0.526833309872813
CR2,Complement receptor type 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36026,-0.0629138802808265,0.0645684509372801,-0.189468044117895,0.0636402835562425,0.329902147257978
CR2,Complement receptor type 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,36026,-0.0278486810977016,0.0399941637064583,-0.10623724196236,0.0505398797669566,0.486251104669629
CR2,Complement receptor type 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36026,0.011488713135915,0.0503732635736177,-0.0872428834683756,0.110220309740206,0.819596821832616
CR2,Complement receptor type 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36026,0.0607454218173293,0.0479658498874327,-0.0332676439620388,0.154758487596697,0.205398670544935
CR2,Complement receptor type 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36026,0.0989652712232176,0.0477714608033246,0.00533320804870144,0.192597334397734,0.0383334688042709
CR2,Complement receptor type 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36026,0.0699562434628593,0.060312512413896,-0.0482562808683769,0.188168767794095,0.246128431329433
CR2,Complement receptor type 2,Mental health,X29076.Felt loved as a child,35938,-0.0680065448863588,0.0457941047949834,-0.157762990284526,0.0217499005118086,0.137573497410647
CR2,Complement receptor type 2,Mental health,X29077.Physically abused by family as a child,35950,0.0468941413907542,0.0592893318709029,-0.0693129490762153,0.163101231857724,0.429006137939608
CR2,Complement receptor type 2,Mental health,X29078.Felt hated by family member as a child,35942,0.0901133548113797,0.0673153837059707,-0.041824797252323,0.222051506875082,0.180718285496866
CR2,Complement receptor type 2,Mental health,X29079.Sexually molested as a child,35926,-0.0625862456616448,0.0980891144646292,-0.254840910012318,0.129668418689028,0.52345785744417
CR2,Complement receptor type 2,Mental health,X29080.Someone to take to doctor when needed as a child,35937,0.00108699979260496,0.0696184764896157,-0.135365214127042,0.137539213712252,0.987543026071645
CR2,Complement receptor type 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35946,0.0576682589972445,0.101862222240909,-0.141981696594937,0.257318214589426,0.571316039671856
CR2,Complement receptor type 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35920,0.00639507071836904,0.086366005687079,-0.162882300428306,0.175672441865044,0.940975682488874
CR2,Complement receptor type 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35958,0.00644529953475203,0.0979984347507555,-0.185631632576729,0.198522231646233,0.947563195358426
CR2,Complement receptor type 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35951,-0.119023386933145,0.309079194337373,-0.724818607834396,0.486771833968106,0.700181687815317
CR2,Complement receptor type 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35945,0.0691472721858653,0.185184144144854,-0.293813650338049,0.432108194709779,0.708863495007845
CR2,Complement receptor type 2,Mental health,X29086.Experienced a violent or sexual assault,35964,-0.195177245076047,0.103610970619989,-0.398254747491225,0.00790025733913022,0.0596380677346442
CR2,Complement receptor type 2,Mental health,X29087.Experienced a life-threatening injury or illness,35955,-0.0115495061054384,0.0516471024161635,-0.112777826841119,0.0896788146302421,0.823056483397503
CR2,Complement receptor type 2,Mental health,X29088.Experienced a marital separation or divorce,35954,-0.0883340386105888,0.0517051203805758,-0.189676074556517,0.0130079973353397,0.08760072676908
CR2,Complement receptor type 2,Mental health,X29089.Experienced the death of a spouse or partner,35965,0.0543869188299145,0.0777474158803772,-0.0979980162956249,0.206771853955454,0.484240805234364
CR2,Complement receptor type 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35958,-0.0110691843897005,0.0636110332969963,-0.135746809651813,0.113608440872412,0.861859568183307
CR2,Complement receptor type 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35952,-0.234951424413109,0.0418470514235199,-0.316971645203208,-0.15293120362301,2.04288168559727e-08
CR2,Complement receptor type 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35347,-0.267769340030913,0.0450420055819717,-0.356051670971578,-0.179487009090249,2.90472220125548e-09
CR2,Complement receptor type 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35368,-0.290441610928854,0.0449554401419956,-0.378554273607165,-0.202328948250542,1.11492894526949e-10
CR2,Complement receptor type 2,Mental health,X29104.Ever used cannabis,35946,-0.132464503529424,0.0571881050262037,-0.244553189380783,-0.0203758176780648,0.0205695788556142
CR2,Complement receptor type 2,Mental health,X29108.Ever thought that life not worth living,35921,0.0718941857028753,0.057005117219882,-0.0398358440480935,0.183624215453844,0.207281212381678
CR2,Complement receptor type 2,Mental health,X29109.Ever contemplated self-harm,35929,0.0850964696649904,0.0808408845933133,-0.0733516641379037,0.243544603467884,0.292540039561487
CR2,Complement receptor type 2,Mental health,X29111.Ever self-harmed,35940,0.0718217132811616,0.142359126823293,-0.207202175292493,0.350845601854817,0.613917639513068
CR2,Complement receptor type 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35940,0.0441301562120381,0.0862271705223579,-0.124875098011783,0.21313541043586,0.608813773116193
CR2,Complement receptor type 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36618,0.0150497238500809,0.0625156262825516,-0.10748090366372,0.137580351363882,0.809766361030575
CR2,Complement receptor type 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36618,0.0280372850533187,0.0486671600043926,-0.0673503485552909,0.123424918661928,0.564561897867156
CR2,Complement receptor type 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36618,0.00484378596631424,0.0605542192172627,-0.113842483699521,0.123530055632149,0.936246496769072
CR2,Complement receptor type 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36618,0.0800106139615014,0.0981319390345718,-0.112327986546259,0.272349214469262,0.41490357646698
CR2,Complement receptor type 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35929,-0.0786656066494811,0.0484666973786886,-0.173660333511711,0.0163291202127486,0.104614085812223
CR2,Complement receptor type 2,Health and medical history,X29153.Pain or discomfort today,35943,0.0571745560004434,0.044261049657135,-0.0295771013275412,0.143926213328428,0.196481707141857
CR2,Complement receptor type 2,Mental health,X29154.Anxiety or depression today,35943,0.144196706509316,0.0597864383290013,0.0270152873844731,0.261378125634158,0.0158956211993956
CR2,Complement receptor type 2,Mental health,X29166.Frequency of confiding in someone close,35770,-0.0303563735064832,0.0443452038173405,-0.11727297298847,0.0565602259755041,0.493651998498253
CR2,Complement receptor type 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35926,0.0239968844825835,0.0124568484604579,-0.000418538499914033,0.0484123074650811,0.0540929728070677
CR2,Complement receptor type 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35926,-0.0250622479485546,0.0128796763100675,-0.0503064135162869,0.000181917619177789,0.0517078736497542
CR2,Complement receptor type 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35926,-0.0279710544308655,0.0136633956148172,-0.0547513098359072,-0.00119079902582381,0.0406787105448005
CR2,Complement receptor type 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35926,0.0312653192915517,0.0189758311581348,-0.00592730977839255,0.0684579483614959,0.0994696590905134
CR2,Complement receptor type 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35926,-0.0549546086539162,0.0377933803424316,-0.129029634125082,0.0191204168172498,0.14596689136595
CR2,Complement receptor type 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35926,0.0022800460318955,0.0138606357802184,-0.0248868000973325,0.0294468921611236,0.869343706582749
CR2,Complement receptor type 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35921,0.0281204069092123,0.0145668441355453,-0.000430607596456571,0.0566714214148811,0.0535910177183622
CR2,Complement receptor type 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35921,-0.0508256061434525,0.0229578300664077,-0.0958229530736117,-0.00582825921329339,0.0268685614038385
CR2,Complement receptor type 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35921,-0.018521359100196,0.0262533918307854,-0.0699780070885353,0.0329352888881433,0.480531265662061
CR2,Complement receptor type 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35921,0.000403610676890414,0.0320718487765201,-0.062457212925089,0.0632644342788699,0.989959567585736
CR2,Complement receptor type 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35921,-0.111342308290015,0.052208249584623,-0.213670477475876,-0.009014139104154,0.0329860174604589
CR2,Complement receptor type 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35921,-0.00543106898858534,0.0211847758940584,-0.0469532297409398,0.0360910917637691,0.797674978193332
CR2,Complement receptor type 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35744,-0.0871896519383082,0.0541218945656282,-0.19326856528694,0.0188892614103231,0.107226806245837
CR2,Complement receptor type 2,Mental health,X29172.Freuency of feeling that lacks companionship,35882,0.0987744307515996,0.0512072658375247,-0.00159181028994879,0.199140671793148,0.0537803167315338
CR2,Complement receptor type 2,Mental health,X29173.Frequency of feeling left out,35852,0.0972544265858238,0.053015585147921,-0.00665612030410132,0.201164973475749,0.0666282116066642
CR2,Complement receptor type 2,Mental health,X29174.Frequency of feeling isolated from others,35886,0.0738625562802745,0.0543391874164778,-0.0326422510560219,0.180367363616571,0.174097705987624
CR2,Complement receptor type 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35936,-0.0845763733660409,0.0438844589373281,-0.170589912883204,0.00143716615112228,0.0539869253071455
CR2,Complement receptor type 2,Mental health,X29176.Ability to make it through stressful events,35936,0.091727166964917,0.0426130605902132,0.0082055682080991,0.175248765721735,0.0313858061656121
CR2,Complement receptor type 2,Mental health,X29177.Quick recovery from stressful events,35936,-0.00792154606227694,0.0435246963519464,-0.0932299509120918,0.077386858787538,0.855586831113176
CR2,Complement receptor type 2,Mental health,X29178.Hard to snap back when something bad happens,35936,0.0999031277513854,0.0428346809939853,0.0159471530031742,0.183859102499597,0.0197120824930204
CR2,Complement receptor type 2,Mental health,X29179.Comes through difficult times with little trouble,35936,-0.0661966547914204,0.0433798040962169,-0.151221070820005,0.0188277612371646,0.127058309058447
CR2,Complement receptor type 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35936,0.0829040842530385,0.0430341670795506,-0.00144288322288058,0.167251051728958,0.0540841655235727
CR2,Complement receptor type 2,Mental health,X29181.General happiness,35898,0.0621858428025485,0.0440240770219742,-0.024101348160521,0.148473033765618,0.15783319817058
CR2,Complement receptor type 2,Mental health,X29182.Belief that own life is meaningful,35797,-0.0567624222469421,0.044655624218046,-0.144287445714312,0.030762601220428,0.20372892951099
CR2,Complement receptor type 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34856,0.098554003151504,0.0440245861847823,0.0122658142293307,0.184842192073677,0.0252161524859292
CR2,Complement receptor type 2,Health and medical history,X2946.Father's age,33564,-0.00270981054399145,0.0107332670069627,-0.0237470138776383,0.0183273927896554,0.800689503913564
CR2,Complement receptor type 2,Health and medical history,X2966.Age high blood pressure diagnosed,35535,-0.0148497442593137,0.00863006572055003,-0.0317646730715918,0.00206518455296434,0.0853500888196861
CR2,Complement receptor type 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51694,0.0224011263182513,0.00365069134640291,0.0152457712793016,0.029556481357201,8.59299938154561e-10
CR2,Complement receptor type 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51695,0.0585651535294718,0.00390233537655806,0.050916576191418,0.0662137308675256,1.13328919274709e-50
CR2,Complement receptor type 2,Blood and urine assays,X30020.Haemoglobin concentration,51695,0.0283426722326866,0.00412460786095621,0.0202584408252124,0.0364269036401607,6.50985038314708e-12
CR2,Complement receptor type 2,Blood and urine assays,X30030.Haematocrit percentage,51695,0.0267733793612548,0.00405033133687364,0.0188347299409825,0.0347120287815271,3.92251333281119e-11
CR2,Complement receptor type 2,Blood and urine assays,X30040.Mean corpuscular volume,51695,-0.0573976066723551,0.00359894311109471,-0.0644515351701008,-0.0503436781746095,5.88421717963473e-57
CR2,Complement receptor type 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51695,-0.0499506609870647,0.00361695285355055,-0.0570398885800238,-0.0428614333941056,3.28826685411711e-43
CR2,Complement receptor type 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51695,0.00112831734878138,0.0035342040860759,-0.00579872265992739,0.00805535735749014,0.74953496307207
CR2,Complement receptor type 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51695,0.00240484086490655,0.00370031199016392,-0.00484777063581475,0.00965745236562784,0.515761867705569
CR2,Complement receptor type 2,Blood and urine assays,X30080.Platelet count,51695,-0.0373841212345752,0.003607230619729,-0.044454293249244,-0.0303139492199064,4.1184393457535e-25
CR2,Complement receptor type 2,Blood and urine assays,X30090.Platelet crit,51695,-0.0290215627828154,0.00367336869153411,-0.0362213654182223,-0.0218217601474086,2.90047473936876e-15
CR2,Complement receptor type 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51695,0.0229016542764053,0.0034172131668677,0.0162039164693446,0.029599392083466,2.10535515050683e-11
CR2,Complement receptor type 2,Blood and urine assays,X30110.Platelet distribution width,51695,0.0319615853222136,0.00350965037239494,0.0250826705923195,0.0388405000521077,9.1576359291372e-20
CR2,Complement receptor type 2,Blood and urine assays,X30120.Lymphocyte count,51657,0.012973947653285,0.00355024202337968,0.00601547328746078,0.0199324220191091,0.000258372058436515
CR2,Complement receptor type 2,Blood and urine assays,X30130.Monocyte count,51657,-0.0011600860194962,0.00356112570020596,-0.00813989239189989,0.00581972035290748,0.744605987517686
CR2,Complement receptor type 2,Blood and urine assays,X30140.Neutrophill count,51657,0.0164259631509784,0.00361188797527793,0.0093466627194337,0.0235052635825232,5.44984348796647e-06
CR2,Complement receptor type 2,Blood and urine assays,X30150.Eosinophill count,51657,0.0231702362626894,0.00343659949680147,0.0164345012489586,0.0299059712764203,1.59693465043372e-11
CR2,Complement receptor type 2,Blood and urine assays,X30160.Basophill count,51657,-0.0113136402083078,0.0259902005717415,-0.0622544333289211,0.0396271529123056,0.663345802457951
CR2,Complement receptor type 2,Blood and urine assays,X30170.Nucleated red blood cell count,51657,0.0226622312856434,0.127916106465365,-0.228053337386472,0.273377799957759,0.859380500848802
CR2,Complement receptor type 2,Blood and urine assays,X30180.Lymphocyte percentage,51658,-0.00165746104770081,0.00351953608279757,-0.00855575176998405,0.00524082967458242,0.637693977487322
CR2,Complement receptor type 2,Blood and urine assays,X30190.Monocyte percentage,51658,-0.0187094912383165,0.00352093367172708,-0.0256105212349016,-0.0118084612417314,1.08366959853483e-07
CR2,Complement receptor type 2,Blood and urine assays,X30200.Neutrophill percentage,51658,0.00283869423097746,0.00347076616068037,-0.00396400744395605,0.00964139590591098,0.413430213525981
CR2,Complement receptor type 2,Blood and urine assays,X30210.Eosinophill percentage,51658,0.0149345402661309,0.00340787402606091,0.00825510717505152,0.0216139733572103,1.17917450866432e-05
CR2,Complement receptor type 2,Blood and urine assays,X30220.Basophill percentage,51658,-0.0145555772119544,0.00355786489296175,-0.0215289924021594,-0.00758216202174934,4.30792424107129e-05
CR2,Complement receptor type 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51656,0.0106636038865796,0.128315546787938,-0.24083486781778,0.262162075590939,0.933769141165668
CR2,Complement receptor type 2,Blood and urine assays,X30240.Reticulocyte percentage,51309,0.0227586673878505,0.00375543651412393,0.0153980118201675,0.0301193229555334,1.38100873878086e-09
CR2,Complement receptor type 2,Blood and urine assays,X30250.Reticulocyte count,51309,0.0347346856518249,0.00378368226029843,0.02731866842164,0.0421507028820099,4.66366834985879e-20
CR2,Complement receptor type 2,Blood and urine assays,X30260.Mean reticulocyte volume,51309,-0.0308839872913492,0.00354713765036863,-0.0378363770860717,-0.0239315974966267,3.3368442164516e-18
CR2,Complement receptor type 2,Blood and urine assays,X30270.Mean sphered cell volume,51309,-0.055509290183884,0.00355799338048868,-0.0624829572096418,-0.0485356231581262,1.37045655045213e-54
CR2,Complement receptor type 2,Blood and urine assays,X30280.Immature reticulocyte fraction,51309,0.00115291859087878,0.00369961485293021,-0.00609832652086443,0.00840416370262199,0.755323028579509
CR2,Complement receptor type 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51309,0.0178199298754885,0.00380875782094718,0.010354764546432,0.025285095204545,2.90402128233881e-06
CR2,Complement receptor type 2,Blood and urine assays,X30300.High light scatter reticulocyte count,51309,0.027190090680837,0.00382010330520717,0.0197026882026309,0.034677493159043,1.13063373615241e-12
CR2,Complement receptor type 2,Blood and urine assays,X30500.Microalbumin in urine,37082,0.0301976972216384,0.00577404111998158,0.0188805766264745,0.0415148178168023,1.73643821960366e-07
CR2,Complement receptor type 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51756,-0.00595255736862314,0.00382686931728086,-0.0134532212304936,0.00154810649324735,0.119849273708045
CR2,Complement receptor type 2,Blood and urine assays,X30520.Potassium in urine,51710,-0.0106404772494733,0.00356872026198506,-0.0176351689629641,-0.00364578553598263,0.00287050217506314
CR2,Complement receptor type 2,Blood and urine assays,X30530.Sodium in urine,51722,-0.00617678122483917,0.00369636531989365,-0.0134216572518307,0.00106809480215239,0.0947269404793274
CR2,Complement receptor type 2,Blood and urine assays,X30600.Albumin,49554,0.0266935534655204,0.00376290415212772,0.0193182613273501,0.0340688456036907,1.34566312130641e-12
CR2,Complement receptor type 2,Blood and urine assays,X30610.Alkaline phosphatase,51280,0.0624390121020429,0.00369149498354569,0.0552036819342933,0.0696743422697924,8.69204385066078e-64
CR2,Complement receptor type 2,Blood and urine assays,X30620.Alanine aminotransferase,51265,0.0370659399306451,0.00400314026467834,0.0292197850118756,0.0449120948494147,2.23704847857471e-20
CR2,Complement receptor type 2,Blood and urine assays,X30630.Apolipoprotein A,49490,-0.0788374164250564,0.00404941857819418,-0.086774276838317,-0.0709005560117958,1.11358312011358e-83
CR2,Complement receptor type 2,Blood and urine assays,X30640.Apolipoprotein B,51116,-0.0149961246376243,0.00347956700314081,-0.0218160759637803,-0.00817617331146831,1.64119562692523e-05
CR2,Complement receptor type 2,Blood and urine assays,X30650.Aspartate aminotransferase,51199,0.0207505136805779,0.00370009367951922,0.0134983300687203,0.0280026972924356,2.0694453079807e-08
CR2,Complement receptor type 2,Blood and urine assays,X30660.Direct bilirubin,49708,0.0170770429485324,0.00377545909617188,0.0096771431200355,0.0244769427770293,6.12520115742866e-06
CR2,Complement receptor type 2,Blood and urine assays,X30670.Urea,51263,0.0323706611724588,0.00362645265470324,0.0252628139692405,0.0394785083756771,4.73366164358489e-19
CR2,Complement receptor type 2,Blood and urine assays,X30680.Calcium,49544,0.0178240749667762,0.00372775172696106,0.0105176815819325,0.0251304683516199,1.75213874628045e-06
CR2,Complement receptor type 2,Blood and urine assays,X30690.Cholesterol,51284,-0.0314266645985689,0.00350351729164452,-0.0382935584901921,-0.0245597707069456,3.18856678293543e-19
CR2,Complement receptor type 2,Blood and urine assays,X30700.Creatinine,51271,0.0410163529562282,0.004515018782587,0.0321669161423577,0.0498657897700987,1.12561107569363e-19
CR2,Complement receptor type 2,Blood and urine assays,X30710.C-reactive protein,51203,0.005450632728452,0.00388221011429307,-0.00215849909556242,0.0130597645524664,0.160331842766323
CR2,Complement receptor type 2,Blood and urine assays,X30720.Cystatin C,51288,0.0737189969959465,0.00415506801652655,0.0655750636835544,0.0818629303083385,5.90876186818813e-70
CR2,Complement receptor type 2,Blood and urine assays,X30730.Gamma glutamyltransferase,51267,0.00577975926263025,0.00423401329295682,-0.0025189067915651,0.0140784253168256,0.172242019996621
CR2,Complement receptor type 2,Blood and urine assays,X30740.Glucose,49520,0.0137529856801533,0.00356219644971795,0.00677108063870609,0.0207348907216004,0.000113348708245922
CR2,Complement receptor type 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51152,0.0256367927934263,0.00359287665773212,0.0185947545442713,0.0326788310425812,9.93900797799362e-13
CR2,Complement receptor type 2,Blood and urine assays,X30760.HDL cholesterol,49531,-0.0881387259148605,0.00418184495702024,-0.0963351420306201,-0.0799423097991008,1.34900671070713e-97
CR2,Complement receptor type 2,Blood and urine assays,X30770.IGF-1,51175,0.0240109749522257,0.00371033010757834,0.0167387279413722,0.0312832219630793,9.91016007194457e-11
CR2,Complement receptor type 2,Blood and urine assays,X30780.LDL direct,51229,-0.0194265141227056,0.00349806121979589,-0.0262827141135055,-0.0125703141319056,2.83136803390837e-08
CR2,Complement receptor type 2,Blood and urine assays,X30790.Lipoprotein A,46692,-0.00500126807491777,0.00383016255893913,-0.0125083866904385,0.00250585054060291,0.191651232510068
CR2,Complement receptor type 2,Blood and urine assays,X30810.Phosphate,49490,-0.00343537453663711,0.00364592352145503,-0.010581384638689,0.00371063556541475,0.346075121668712
CR2,Complement receptor type 2,Blood and urine assays,X30830.SHBG,49397,-0.0132038887914618,0.00484842410903765,-0.0227068000451756,-0.003700977537748,0.00646801733337223
CR2,Complement receptor type 2,Blood and urine assays,X30840.Total bilirubin,51186,0.0169407764139668,0.00382056193992037,0.00945247501172292,0.0244290778162108,9.28910518668923e-06
CR2,Complement receptor type 2,Blood and urine assays,X30850.Testosterone,51050,-0.0244520446095878,0.00599609813732356,-0.036204396958742,-0.0126996922604336,4.55827671243578e-05
CR2,Complement receptor type 2,Blood and urine assays,X30860.Total protein,49520,0.0225781619150772,0.0036933179369302,0.015339258758694,0.0298170650714604,9.9353309398508e-10
CR2,Complement receptor type 2,Blood and urine assays,X30870.Triglycerides,51257,0.0270786122008682,0.00366620851593888,0.019892843509628,0.0342643808921084,1.56542666241409e-13
CR2,Complement receptor type 2,Blood and urine assays,X30880.Urate,51251,0.0184277616453239,0.00438610602075503,0.00983099384464401,0.0270245294460037,2.66290944042185e-05
CR2,Complement receptor type 2,Blood and urine assays,X30890.Vitamin D,50593,-0.00656062457395009,0.0039489693442934,-0.0143006044887651,0.00117935534086497,0.096657205260984
CR2,Complement receptor type 2,Physical measures,X3137.Number of measurements made,49967,-0.00331786609434176,0.0315019722870511,-0.0650617317769619,0.0584259995882784,0.916120908151262
CR2,Complement receptor type 2,Physical measures,X3143.Ankle spacing width,42062,0.00643162236053781,0.0063313361854598,-0.00597779656296339,0.018841041284039,0.309724005754576
CR2,Complement receptor type 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42061,0.000575084277463764,0.00461699851812151,-0.0084742328180544,0.00962440137298192,0.900875310214322
CR2,Complement receptor type 2,Physical measures,X3146.Speed of sound through heel,42062,0.000509333780118117,0.00446123407248936,-0.00823468500196102,0.00925335256219726,0.909105679705616
CR2,Complement receptor type 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42062,0.00051663470867449,0.00450326962123432,-0.00830977374894478,0.00934304316629376,0.90866531880341
CR2,Complement receptor type 2,Physical measures,X3148.Heel bone mineral density (BMD),42042,-0.000742708049923622,0.00453033985212003,-0.00962217416007889,0.00813675806023164,0.869780123967427
CR2,Complement receptor type 2,Health and medical history,X3526.Mother's age at death,42814,-0.000667671042150437,0.00468690802291552,-0.00985401076706486,0.00851866868276399,0.886723051899974
CR2,Complement receptor type 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32997,0.0207869525690109,0.00795636312641891,0.00519248084122981,0.0363814242967919,0.00901569720256483
CR2,Complement receptor type 2,Physical measures,X4100.Ankle spacing width (left),36227,0.0137300674478524,0.00863368776040335,-0.00319196056253817,0.0306520954582429,0.111810893671119
CR2,Complement receptor type 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36225,0.000515760553163701,0.00623283453984128,-0.0117005951449252,0.0127321162512526,0.934053328862175
CR2,Complement receptor type 2,Physical measures,X4103.Speed of sound through heel (left),36227,0.000534451341689424,0.00596911417711735,-0.0111650124454606,0.0122339151288394,0.928658197737251
CR2,Complement receptor type 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36227,0.000728243014817969,0.0060518946584748,-0.0111334705157926,0.0125899565454286,0.904222484336932
CR2,Complement receptor type 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),36217,0.00107966348273294,0.00608122322638491,-0.0108395340409815,0.0129988610064474,0.859088567822412
CR2,Complement receptor type 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36227,0.000724771403940423,0.00605227331336266,-0.0111376842902504,0.0125872270981312,0.904682817003166
CR2,Complement receptor type 2,Physical measures,X4119.Ankle spacing width (right),36214,0.0106383945343795,0.00846352846349752,-0.00595012125407566,0.0272269103228346,0.208803348742002
CR2,Complement receptor type 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36213,-0.00298989730115928,0.0062564394715073,-0.0152525186653136,0.00927272406299503,0.632741373528484
CR2,Complement receptor type 2,Physical measures,X4122.Speed of sound through heel (right),36214,-4.76360492030072e-05,0.00594648036222095,-0.0117027375591561,0.01160746546075,0.993608586695831
CR2,Complement receptor type 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36214,-0.000989234767819169,0.00604636395763227,-0.0128401081247784,0.0108616385891401,0.870043925627619
CR2,Complement receptor type 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),36202,-0.00326062108801539,0.00607735232498238,-0.0151722316449809,0.00865098946895007,0.591614914754939
CR2,Complement receptor type 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36214,-0.000985592543090968,0.00604636947863743,-0.0128364767212203,0.0108652916350384,0.870518291744052
CR2,Complement receptor type 2,Physical measures,X4194.Pulse rate,36603,0.00946586993395141,0.00564672281938138,-0.00160170679203609,0.0205334466599389,0.0937091955777433
CR2,Complement receptor type 2,Physical measures,X4195.Pulse wave reflection index,36603,-0.0116787331557217,0.00591717615069949,-0.0232763984110927,-8.10679003507373e-05,0.0484501579246728
CR2,Complement receptor type 2,Physical measures,X4196.Pulse wave peak to peak time,36596,-0.00197062432519367,0.0065271428874,-0.0147638243844977,0.0108225757341103,0.762726817150921
CR2,Complement receptor type 2,Physical measures,X4198.Position of the pulse wave peak,36603,0.00353426275281187,0.00705211921849528,-0.0102878909154389,0.0173564164210626,0.616270043089783
CR2,Complement receptor type 2,Physical measures,X4199.Position of pulse wave notch,36603,0.0121879673653881,0.00573171158572264,0.000953812657371761,0.0234221220734045,0.0334996731762644
CR2,Complement receptor type 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36603,0.00870626639385471,0.00718188891842828,-0.00537023588626472,0.0227827686739741,0.225451334854879
CR2,Complement receptor type 2,Physical measures,X4269.Number of triplets attempted (left),36379,0.0230122149553307,0.124269537532657,-0.220556078608677,0.266580508519338,0.853092805511936
CR2,Complement receptor type 2,Physical measures,X4270.Volume level set by participant (left),36289,-0.0259946262500603,0.040014222458269,-0.104422502268268,0.052433249768147,0.515947645361389
CR2,Complement receptor type 2,Physical measures,X4276.Number of triplets attempted (right),36382,0.189863459133284,0.121991902867331,-0.0492406704866845,0.428967588753252,0.119662968794498
CR2,Complement receptor type 2,Physical measures,X4277.Volume level set by participant (right),36293,0.00402660392915319,0.0395267800034186,-0.0734458848775473,0.0814990927358537,0.918862300674403
CR2,Complement receptor type 2,Cognitive function,X4288.Time to answer,36565,-0.00311808894768826,0.0067641027869718,-0.016375730410153,0.0101395525147765,0.644828420883572
CR2,Complement receptor type 2,Cognitive function,X4290.Duration screen displayed,36565,0.00813527654308996,0.0063088833804365,-0.00423013488256557,0.0205006879687455,0.197263332606128
CR2,Complement receptor type 2,Physical measures,X46.Hand grip strength (left),52307,-0.011633783669554,0.00465685333031159,-0.0207612161969647,-0.0025063511421433,0.0124890457739417
CR2,Complement receptor type 2,Physical measures,X47.Hand grip strength (right),52308,-0.0118697942438674,0.00459793230896656,-0.0208817415694418,-0.00285784691829292,0.00984170750757338
CR2,Complement receptor type 2,Physical measures,X48.Waist circumference,52364,0.0423193151509936,0.00869518657036883,0.0252767494730707,0.0593618808289165,1.14041749937512e-06
CR2,Complement receptor type 2,Health and medical history,X4803.Tinnitus,36417,0.0915348699409809,0.0450556037501194,0.00322588659074695,0.179843853291215,0.0422281486718756
CR2,Complement receptor type 2,Working and living environment,X4825.Noisy workplace,36498,-0.0417626306547483,0.0433837617226274,-0.126794803631098,0.0432695423216015,0.335761325340385
CR2,Complement receptor type 2,Working and living environment,X4836.Loud music exposure frequency,36447,-0.0337059264318463,0.0589558150282872,-0.149259323887289,0.0818474710235967,0.567531419939874
CR2,Complement receptor type 2,Physical measures,X49.Hip circumference,52358,0.0166459730472047,0.00641931437486198,0.0040641168724752,0.0292278292219342,0.00951712997890833
CR2,Complement receptor type 2,Physical measures,X50.Standing height,52315,0.0154023883900076,0.00485959797999537,0.00587757634921671,0.0249272004307986,0.0015290708005849
CR2,Complement receptor type 2,Health and medical history,X5057.Number of older siblings,35558,-0.0470008136456579,0.0424054002714003,-0.130115398177603,0.0361137708862867,0.267740980310703
CR2,Complement receptor type 2,Physical measures,X51.Seated height,52211,0.0140128601518184,0.00422144765057738,0.00573882275668671,0.0222868975469501,0.000903333335307312
CR2,Complement receptor type 2,Eye measures,X5181.Ever had eye surgery,33957,0.0692680905498583,0.0962937442550975,-0.119467648190133,0.258003829289849,0.471961895464312
CR2,Complement receptor type 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33945,0.00336316347384632,0.00727295831432035,-0.0108918348222216,0.0176181617699142,0.643798776342635
CR2,Complement receptor type 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33941,0.00507580297971388,0.00752777356862698,-0.009678633214795,0.0198302391742228,0.500164540633845
CR2,Complement receptor type 2,Eye measures,X5190.Duration at which refractometer first shown (right),33889,0.0065364097975771,0.00753472767570191,-0.00823165644679865,0.0213044760419529,0.385705030440452
CR2,Complement receptor type 2,Eye measures,X5193.Duration at which refractometer first shown (left),33885,0.00410663073329522,0.00757811699116483,-0.0107464785693878,0.0189597400359783,0.58790577526284
CR2,Complement receptor type 2,Eye measures,"X5199.logMAR, initial (right)",33924,-0.0383894073690359,0.0502022189300794,-0.136785756471992,0.0600069417339197,0.444486826854255
CR2,Complement receptor type 2,Eye measures,X5200.Final number of letters displayed (right),33924,-0.4154747905004,0.300573577777582,-1.00459900294446,0.173649421943662,0.166945848753771
CR2,Complement receptor type 2,Eye measures,"X5201.logMAR, final (right)",33863,-0.0117774952566469,0.00722047282834164,-0.0259296220001965,0.00237463148690274,0.102923734973597
CR2,Complement receptor type 2,Eye measures,X5202.Number of rounds to result (right),33924,0.0227877176243167,0.0474151607588276,-0.0701459974629854,0.115721432711619,0.630820733084665
CR2,Complement receptor type 2,Eye measures,"X5206.logMAR, initial (left)",33919,0.0279392708383852,0.0501941644970626,-0.0704412915758574,0.126319833252628,0.577807852886292
CR2,Complement receptor type 2,Eye measures,X5207.Final number of letters displayed (left),33919,-0.329492688934846,0.297486438155277,-0.91256610771919,0.253580729849497,0.26808948392633
CR2,Complement receptor type 2,Eye measures,"X5208.logMAR, final (left)",33872,-0.000237530252406847,0.00728951642220127,-0.0145249824399213,0.0140499219351076,0.974006616502594
CR2,Complement receptor type 2,Eye measures,X5209.Number of rounds to result (left),33915,0.0187685416660941,0.0475811498403894,-0.0744905120210692,0.112027595353257,0.693262256845216
CR2,Complement receptor type 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33718,-0.00302095292626399,0.00719287498187822,-0.0171189878907453,0.0110770820382173,0.674508625810015
CR2,Complement receptor type 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33718,-0.00233680204714951,0.00704495300876838,-0.0161449099443355,0.0114713058500365,0.740130332709935
CR2,Complement receptor type 2,Eye measures,X5256.Corneal hysteresis (right),33718,0.00451383438512516,0.0073112864328071,-0.00981628702317675,0.0188439557934271,0.537012264918846
CR2,Complement receptor type 2,Eye measures,X5257.Corneal resistance factor (right),33718,0.00251079240188821,0.00720017752780668,-0.0116015555526129,0.0166231403563893,0.727319451268893
CR2,Complement receptor type 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33691,0.00111976844017402,0.00726221980597978,-0.0131141823795464,0.0153537192598944,0.877465303681297
CR2,Complement receptor type 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33691,0.00359218936032889,0.00717948785497029,-0.0104796068354129,0.0176639855560707,0.61685688828203
CR2,Complement receptor type 2,Eye measures,X5264.Corneal hysteresis (left),33691,0.00363076517079362,0.00721670684051432,-0.0105139802366145,0.0177755105782017,0.614911838561628
CR2,Complement receptor type 2,Eye measures,X5265.Corneal resistance factor (left),33691,0.00308750894582443,0.00716445361794667,-0.010954820145351,0.0171298380369999,0.666524224021539
CR2,Complement receptor type 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34632,-0.103177844224251,0.225999455684129,-0.546136777365144,0.339781088916642,0.648017986767228
CR2,Complement receptor type 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52296,-0.015077442755811,0.0189838932785968,-0.0522858735818606,0.0221309880702387,0.427073633483195
CR2,Complement receptor type 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52296,-0.0148861558419029,0.0220779418122649,-0.0581589217939422,0.0283866101101363,0.500155981662713
CR2,Complement receptor type 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52296,0.139447891216727,0.0544564506626466,0.03271324791794,0.246182534515515,0.0104515960552343
CR2,Complement receptor type 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52296,0.0182923280501026,0.0086443049600434,0.00134949032841752,0.0352351657717876,0.0343455782370113
CR2,Complement receptor type 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52296,-0.0162078592597524,0.00801687296582996,-0.0319209302727791,-0.000494788246725674,0.0432166729316537
CR2,Complement receptor type 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38984,-0.00924369704023962,0.0105638277756707,-0.0299487994805541,0.0114614054000749,0.38157623357602
CR2,Complement receptor type 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38984,-0.0034257697729116,0.0329154011893932,-0.0679399561041223,0.0610884165582991,0.9171094438639
CR2,Complement receptor type 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38984,-0.057235828065578,0.0203947574564988,-0.0972095526803157,-0.0172621034508403,0.00501918987933919
CR2,Complement receptor type 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38984,-0.0104534947504273,0.0122594861114003,-0.0344820875287718,0.0135750980279172,0.393853006461581
CR2,Complement receptor type 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52367,0.000145769638204251,0.0182860751226458,-0.0356949376021814,0.0359864768785899,0.993639701919683
CR2,Complement receptor type 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52367,0.000145769638204251,0.0182860751226458,-0.0356949376021814,0.0359864768785899,0.993639701919683
CR2,Complement receptor type 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52367,0.00915185896535852,0.0133667530513574,-0.0170469770153019,0.035350694946019,0.49355677556869
CR2,Complement receptor type 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52367,0.0228468188885805,0.0236849837962952,-0.0235757493521581,0.069269387129319,0.334749015993847
CR2,Complement receptor type 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52367,0.163832753678058,0.0551710887933117,0.0556974196431676,0.271968087712949,0.00298543786165136
CR2,Complement receptor type 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52367,0.106972978038302,0.0390170466376679,0.0304995666284725,0.183446389448131,0.00611681273084463
CR2,Complement receptor type 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52367,-0.0648824765498807,0.0578386865868997,-0.178246302260204,0.0484813491604426,0.261965893416118
CR2,Complement receptor type 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52295,-0.0149970501451194,0.0118474520586398,-0.0382180561800535,0.0082239558898146,0.205580657747423
CR2,Complement receptor type 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52295,0.0242301156461536,0.0209311172544121,-0.016794874172494,0.0652551054648013,0.247034017337535
CR2,Complement receptor type 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52295,0.017045299811695,0.0108141630981419,-0.00415045986066311,0.038241059484053,0.114992728948876
CR2,Complement receptor type 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52295,0.0024296702043803,0.0160428589964085,-0.0290143334285804,0.033873673837341,0.879623061524628
CR2,Complement receptor type 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52295,-0.0183129087557743,0.0161559179107335,-0.049978507860812,0.0133526903492634,0.257011242445391
CR2,Complement receptor type 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52295,0.014721105726037,0.00912197797965676,-0.00315797111409021,0.0326001825661643,0.10658275889606
CR2,Complement receptor type 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37148,0.0051312934546421,0.0176686607555732,-0.0294992816262813,0.0397618685355655,0.771503678512198
CR2,Complement receptor type 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37148,-0.0448079277131243,0.0168638286734971,-0.0778610319131787,-0.01175482351307,0.00789757678489223
CR2,Complement receptor type 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37148,0.0216497827915887,0.0244857273593784,-0.026342242832793,0.0696418084159703,0.376624088808385
CR2,Complement receptor type 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37148,0.0473868315592861,0.0182872714149842,0.011543779585917,0.0832298835326552,0.00957914457379544
CR2,Complement receptor type 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52245,0.00991053594920966,0.0321450717982575,-0.053093804775375,0.0729148766737943,0.757851803972616
CR2,Complement receptor type 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52245,0.0256457272578417,0.0399768945343583,-0.0527089860295005,0.104000440545184,0.521195172974225
CR2,Complement receptor type 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52245,0.0411710974586733,0.0795228365313437,-0.11469366214276,0.197035857060107,0.604653795099712
CR2,Complement receptor type 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52245,-0.11306339107474,0.0760348913557243,-0.26209177813196,0.0359649959824795,0.137029855281848
CR2,Complement receptor type 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52245,0.0114776233559813,0.0304704956527937,-0.0482445481234943,0.0711997948354569,0.706414879540153
CR2,Complement receptor type 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52245,0.0350242249986696,0.0356898395359629,-0.0349278604918176,0.104976310489157,0.326430201243413
CR2,Complement receptor type 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52245,-0.00686947747735204,0.0150478430046318,-0.0363632497664303,0.0226242948117262,0.64802811170265
CR2,Complement receptor type 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35706,0.0204399224584143,0.0254244834558683,-0.0293920651150875,0.0702719100319161,0.421454812382212
CR2,Complement receptor type 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35706,0.0105853223908095,0.0250675367892706,-0.0385470497161608,0.0597176944977798,0.672839166946254
CR2,Complement receptor type 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35706,0.0808655438952579,0.0351431191567992,0.0119850303479314,0.149746057442584,0.0214184654679232
CR2,Complement receptor type 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35706,-0.0104310935025537,0.0127983034865893,-0.0355157683362686,0.0146535813311613,0.415078328855567
CR2,Complement receptor type 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38850,0.0112193835412887,0.0112197058861912,-0.0107712399956461,0.0332100070782236,0.317348017465145
CR2,Complement receptor type 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38850,-0.0174365699071174,0.0124046730388839,-0.0417497290633298,0.00687658924909507,0.159859797867602
CR2,Complement receptor type 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38850,0.00616220290669892,0.0109824389026009,-0.0153633773423988,0.0276877831557966,0.574744337667816
CR2,Complement receptor type 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38851,0.0202580897462755,0.0255310492075102,-0.0297827667004445,0.0702989461929955,0.427523133586317
CR2,Complement receptor type 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38851,-0.00580825485874434,0.0152703919369588,-0.0357382230551836,0.0241217133376949,0.703685666327648
CR2,Complement receptor type 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38851,0.0180057566452483,0.0276677972251606,-0.0362231259160665,0.0722346392065631,0.515200588590319
CR2,Complement receptor type 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52295,-0.0253191473663015,0.0234292470722309,-0.0712404716278741,0.0206021768952711,0.279857534467979
CR2,Complement receptor type 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52295,0.0238778270102601,0.018945556863977,-0.0132554644431349,0.061011118463655,0.207559454396163
CR2,Complement receptor type 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52295,0.0220552886678124,0.0373782279383936,-0.0512060380914391,0.0953166154270638,0.555157997534902
CR2,Complement receptor type 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52295,-0.00246930212624266,0.021006604067938,-0.0436422460994011,0.0387036418469158,0.906426132867221
CR2,Complement receptor type 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52295,0.0407065646516946,0.0215851060652869,-0.0016002432362677,0.0830133725396568,0.0593255655629042
CR2,Complement receptor type 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52295,-0.0168662471348818,0.0260851461129987,-0.0679931335163591,0.0342606392465956,0.517907254807773
CR2,Complement receptor type 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52295,0.0169756129396875,0.00756511815576668,0.00214798135438485,0.0318032445249902,0.0248459531574161
CR2,Complement receptor type 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34217,0.030381376916533,0.0192229795984418,-0.00729566309641295,0.068058416929479,0.114055168012943
CR2,Complement receptor type 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34217,0.0669481022303606,0.0230142050753923,0.0218402602825918,0.11205594417813,0.00364020275891935
CR2,Complement receptor type 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34217,-0.0108638804429091,0.0171783194202516,-0.0445333865066022,0.022805625620784,0.527139439123415
CR2,Complement receptor type 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34217,0.001980893754383,0.0152588192331815,-0.0279263919426526,0.0318881794514186,0.896713806845678
CR2,Complement receptor type 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52403,0.00880545909225051,0.00922354744839828,-0.00927269390661012,0.0268836120911111,0.339753475025539
CR2,Complement receptor type 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52403,0.04894040054933,0.0303303104652766,-0.0105070079626121,0.108387809061272,0.10663168345593
CR2,Complement receptor type 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52403,0.0121211051495086,0.00810705609015737,-0.0037687247871998,0.0280109350862171,0.134893698086587
CR2,Complement receptor type 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52403,-0.00496956420062618,0.00758199757850145,-0.019830279454489,0.00989115105323665,0.512189166351316
CR2,Complement receptor type 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52403,0.0275200174994578,0.0128261810219985,0.00238070269634078,0.0526593323025747,0.0319139711982557
CR2,Complement receptor type 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52403,-0.00523651581246415,0.011566022578701,-0.0279059200667181,0.0174328884417898,0.650732954275265
CR2,Complement receptor type 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52403,-7.13926531980953e-06,0.00817119869329964,-0.0160226887041871,0.0160084101735475,0.999302886977068
CR2,Complement receptor type 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52403,0.0349011176155411,0.0265811459735648,-0.0171979284926458,0.0870001637237281,0.189194681102035
CR2,Complement receptor type 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45190,-0.0166638798844507,0.00834123008286495,-0.033012690846866,-0.000315068922035398,0.0457576304515494
CR2,Complement receptor type 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45190,-0.0431436543771299,0.00819588758843598,-0.0592075940504644,-0.0270797147037954,1.42662894966383e-07
CR2,Complement receptor type 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45190,0.0693880380109564,0.0106013227686729,0.0486094453843576,0.0901666306375553,6.11470510809866e-11
CR2,Complement receptor type 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45191,0.0293791566628634,0.0164928001845776,-0.0029467316989087,0.0617050450246356,0.0748764794296068
CR2,Complement receptor type 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45191,0.0118546056991381,0.00937861360005573,-0.00652747695697113,0.0302366883552473,0.206246326816679
CR2,Complement receptor type 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52178,0.000726997918003605,0.00868730838653379,-0.0163001265196026,0.0177541223556098,0.933307546818713
CR2,Complement receptor type 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52178,-0.00169251337452232,0.00683544555050315,-0.0150899866535085,0.0117049599044639,0.804439607834155
CR2,Complement receptor type 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52178,0.00936508278107069,0.00771872159760713,-0.00576361155023929,0.0244937771123807,0.225029383681276
CR2,Complement receptor type 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52178,-0.0401051477700564,0.0118113415494236,-0.0632553772069267,-0.0169549183331861,0.000686218808928463
CR2,Complement receptor type 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52201,-0.0168621813414744,0.00735600143163578,-0.0312799441474805,-0.00244441853546824,0.0218969451138978
CR2,Complement receptor type 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52201,-0.0405283752938162,0.0102635561617529,-0.0606449453708518,-0.0204118052167806,7.87832509747145e-05
CR2,Complement receptor type 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52295,-0.00695033471368522,0.00750788671481255,-0.0216657926747178,0.00776512324734737,0.354591673987609
CR2,Complement receptor type 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52295,-0.0257199695188863,0.00941046509590697,-0.0441644811068639,-0.00727545793090861,0.00627832101120829
CR2,Complement receptor type 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52295,0.00395524716876299,0.0200644943570766,-0.0353711617711072,0.0432816561086332,0.843730095796799
CR2,Complement receptor type 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52295,-0.0158143048710477,0.0183788230985997,-0.0518367981443031,0.0202081884022077,0.389542348754631
CR2,Complement receptor type 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52295,0.010442587860311,0.0221949372941483,-0.0330594892362197,0.0539446649568418,0.638006352951041
CR2,Complement receptor type 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52295,-0.0236508144139513,0.0229163586956735,-0.0685668774574713,0.0212652486295687,0.30205950622073
CR2,Complement receptor type 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42062,0.000521704796281898,0.00450328181100433,-0.00830472755328659,0.00934813714585039,0.907773221633196
CR2,Complement receptor type 2,Physical activities,X864.Number of days or week walked 10+ minutes,51924,-0.051749133883437,0.0231091495287766,-0.0970430669598391,-0.00645520080703493,0.0251434980112096
CR2,Complement receptor type 2,Physical activities,X874.Duration of walks,49264,-0.00210316870624343,0.00351052146454469,-0.00898379077675102,0.00477745336426416,0.549109863924683
CR2,Complement receptor type 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51322,-0.0920958468507938,0.0225180804539939,-0.136231284540622,-0.0479604091609658,4.331161536916e-05
CR2,Complement receptor type 2,Physical activities,X894.Duration of moderate activity,46517,-0.0196717944057924,0.0270648336687052,-0.0727188683964545,0.0333752795848698,0.467333683144791
CR2,Complement receptor type 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33348,-0.0170700397638284,0.00785286096027858,-0.0324616472459744,-0.0016784322816824,0.0297742820724403
CR2,Complement receptor type 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51248,-0.127618268689205,0.0230572296000781,-0.172810438705358,-0.0824260986730516,3.14949505558462e-08
CR2,Complement receptor type 2,Physical activities,X914.Duration of vigorous activity,42145,-0.00987674420032237,0.00418270140651304,-0.0180748389570879,-0.00167864944355682,0.0182235254891483
